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Inflammation is a normal protective response of the body to a 
noxious stimulus. It is a response aimed towards localizing and 
neutralizing the effects of that noxious stimulus and towards 
effecting tissue repair in those areas damaged by that stimulus. 
Since it is a process directed toward the maintainence of the con-
stancy of the body, inflammation may be considered a homeostatic 
mechantsm. However, like other homeostatic mechanisms, the in-
flammatory process is subject to loss of control and sometimes 
can cause more_ harm than the original injury. 
When tissue injury is caused by a single finite event, such 
as mechanical trauma, a thermal or chemical burn, or a single 
exposure to a non-replicating antigen, the inflammatory process 
is "acute" and progresses smoothly from injury to healing. Under 
these circunstances, the process is truly beneficial and provides 
an example of a homeostatic mechanism restoring the affected 
tissue to its former normal and helathy state. In contrast, when 
the injurious agent is a self-replicating parasite such as a 
bacterium or virus (which cannot be destroyed or readily elimin-
ated), the ensuing inflammatory response becomes more complex and 
does not always progress smoothly from injury to healing. Under 
1 
these circumstances, the inflammatory response becomes "chronic ... 
Homeostasis is not achieved; instead, tissue injury persists, not 
only as a result of the continuing existence of the noxious agent, 
but also as a result of the "loss of control" which develops within 
the inflammatory response itself. 
The expression of inflammation, therefore, represents a 
spectrum, with the response varying from an acute, transient, and 
highly localized response to a complex, chronic, and sustained 
response, perhaps involving the whole organism. In spite of the 
fact that many types of stimuli can cause inflammation and that 
many degrees of inflammation can result, the inflammatory process 
itself always seems to follow an orderly biochemical and morpho-
logical sequence, and the difference in complexity between the 
types of inflammatory states is more quantitative than qualitative (1). 
The clinical expression of the process was described as early 
as the first century A.D. by the Roman encylopedlst, Celsus. His 
classic description of the process consisted of calor (heat), rubor 
(redness), tumor (swelling), and dolor (pain). Galen (A.D. 130-200) 
subsequently added function laesa (loss of function) (2). We now 
know that each of these observable manifestations of inflammation 
represents certain biochemical and morphological changes. 
The pattern of biochemical and morphological changes which occur 
following any type of tissue injury may be summarized as follows: 
(i) vascular changes in the microcirculation, 
(ii) migration of cellular mediators to the injured area and 
a "walling off" process, plus 
(iii) connective tissue proliferation. 
2 
Vascular Changes, Immediately following tissue injury or irritation, 
there is a brief arteriolar vasoconstriction (J), followed in a few 
seconds by vasodilation of the arterioles, capillaries, and venules (4). 
During this period of vasodilation, blood flow first quickens, then 
becomes sluggish or even stops. This stasis of blood is due to a loss 
of water primarily from the venules. This water loss ls due to marked 
increase in the permeability of the venules to the plasma proteins 
which, upon leaking into the extravascular spaces, disturb the osmotic 
balance which previously maintained water within the vascular system. 
The endothelial cells lining these vessels may also become damaged 
and swollen an narrow the lumen of the microcirculatory system. In 
addition, polymorphonuclear phagocytes (PMN phagocytes) adhere and 
begin to· accumulate along the margin of the vasculature and further 
narrow the lumen. All this results in further stasis of blood and 
increased edem?" formation (5). 
Many possible mediators have been implicated in this "initial 
vascular" phase of inflammation. Histamine, bradykinin, and the 
prostaglandins are a few examples of the chemical substances that 
are found at the inflammatory site and probably responsible for the 
vasodilation and increased vessel permeability (1). 
As soon as tissue injury occurs, the mast cells release both 
histamine and heparin. Histamine causes an immediate increase in 
vessel permeability. The role o£ heparin is more difficult to 
evaluate, but it has been suggested that it serves to prevent 
thrombosis of the small vessels at the site of the injury. Slightly 
later, kinins are produced and these potent substances have the 
capacity to activate pain sensors in addition to a histamine-like 
effect on venule permeability (6). The kinins are formed from an 
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ever-present plasma kininogen, and their formation is generated via 
a sequential involvement of three factors: Hageman factor, perme-
ability factor, and kallikrein (?). Both histamine and the kinins 
have been shown to increase venule permeability by causing gaps 
to appear between the endothelial cells, thus allowing interendo-
thelial leakage of protein and exit routes for phagocytes (8). 
The prostaglandins may also be responsible for some of the 
vasodilation l'ritnessed during this early phase of the inflammatory 
!-----~I:es~<JI1.-se-.-~Gstag-1anEl-i-n-s-h-a-~.;-e-been-de~ected--i:n-bl-i-ster--f-lll1d-arrd---------~ 
perfusates of the skin of patients with contact derrratitis. In 
animals, they have been detected in experimental inflammatory 
states such as skin burns in dogs and carrageenin-induced pedal 
edema in the rat (9), While there is no doubt that prostaglandins 
are formed in inflammatory states, it should be understood that 
not all species of prostaglandins promote vasodilation. One 
prostaglandin may actually have an opposing action to that of 
another prostaglandin in an inflammatory state (10). Therefore, one 
has to be concerned both with the identification of the prostaglandic 
inflammogens present and the ratio be~ween the pro-prostaglandic 
inflammogens and the anti-prostaglandic inflammogens which originate 
within the injured tissue, 
In summary, the initial vascular phase of inflammation appears 
to be initiated by histamine released from the mast cells and pro·-
longed (although only briefly) by polypeptide kinins and the acid 
prostaglandins. Since these tissue hormones or autacoids are 
formed or released in situ and their duration of action is so brief, 
it is hard to believe that they could be "primarily" responsible 
for the tissue injury of chronic inflammation. Nevertheless, they are 
undoubtedly ve17 important in the triggering of the acute inflam-
matory state. 
Serotonin, the catecholamines, and the adenylates (cyclic AMP and 
ADP) may also be classified as mediators in the inflammatory response, 
although their roles are much less clearly defined. For example, the 
effect of serotonin shows variability between species and often little 
resemblance to changes seen in man. In rodents, serotonin causes a 
combination of arteriolar dilation and separation of endothellal cells. 
no prominent effects upon vasodilation (3). The permeability-enhancing 
property of serotonin in man thus seems nonexistent, but this does not 
eliminate serotonin from having a possible role as a mediator in inflam-
mation since there is ample evidence that mediators are chemically, 
physiologically, and pharmacologically interrelated (11). Thus, the 
active contribution of serotonin may not be dramatic, but it may be 
critical for the direct effect of other mediators. 
The catecholamines generally are not considered as mediators 
of inflammation. Yet, like serotonin, they too may alter the 
manifestations of the inflammatory process. It is thought that 
they may act locally during the inflammatory process as endogenous 
anti-inflammatory hormones (12). More information, however, is 
needed before the direct and/or indirect roles of the catecholamines 
during inflammation can be defined. The role of the adenylates is much 
like that of the prostaglandins. They may be key participants in 
amplifying the inflammatory state, but again, since it has been 
demonstrated in other contexts that cyclic GMP may elicit responses 
diametrically opposed to those elicited by cyclic AMP, it is their 
ratios which must be defined and not merely their presence (10). 
5 
Migration of Cellular Mediators to the Injured Are~. Immediately 
following the early vascular events, a greater number of PMN 
leukocytes appear at the injured area. Several effects occur to 
cause the movement of these cells (particularly neutrophils) to 
the injured area. First, the neutrophils stick to the walls of the 
damaged capillaries. This is a process known as margination. 'I'he 
total number of g~anulocytes available in the blood during tissue 
injury is increased above normal, since a globulin substance 
known as leukocytosis-promoting factor is liberated by inflammed 
tissues. This factor diffuses into the blood and bone marrow 
where it has the effect of causing large numbers of granulocytes, 
expecially neutrophils, to be released from the storage areas in 
the bone marrow into the blood (13). The second effect is a chemo-
taxis of the neutrophils toward the damaged area. This is caused 
by certain of the substances released or activated by the inflammatory 
stimulus. r1any of the suggested inflammatory mediators as well as 
the immunologically activated complement components are purported to 
have chemotaxic properties (14). Electron microscopic studies 
have demonstrated that the PMN phagocytes leave the inflammed 
vessels by inserting pseudopodia down through the interendothelial 
gaps, with cytoplasm then flowing through these pseudopodia until 
the cell has completely left the lumen. It then lies between the 
endothelium and the endothelial basement membrane. The PMN 
phagocyte then passes through the basement membrane, perhaps by 
enzyme action, with the membrane reforming immediately after its 
passage (15). Once these phagocytes have emigrated through the 
vessel wall, they begin to ingest and digest or kill the "noxious" 
6 
'1 
agent. This is accomplished by the release of lysozomal enzymes 
which unfortunately may also cause further tissue destruction and 
edema formation. Thus, it is apparent that leukocytes play more 
than one role in the inflammatory process. On the one hand, they 
seem to help resolve inflammation by ridding the area of the 
''noxious stimulus," while on the other hand, they serve to promote 
the process by causing further tissue damage and consequently 
the release of more inflammation-promoting substances (16). 
--~~-----------------------
P!1N' leukocytes are the predominant cells in the inflammed 
tissue during the early phases of the inflammatory process. Later, 
however, monocytes and macrophages are more numerous, There are 
several factors responsible for this shift. First, it appears 
that mononuclear phagocytes migrate slower than PMN phagocytes. 
Second, the mononuclear phagocytes depend, in part, upon the poly-
morphs for their chemotactic signal. Third, and perhaps most 
important, however, is the fact that with time the affected area 
becomes acidic, and P~m cells, particularly neutrophils, cannot 
live in an acid environment, whereas macrophages live well m1der 
acid conditions -- their proteolytic enzymes actually becoming more 
active. ~ourth, is the fact that mononuclear phagocytes are longer 
lived than the P~m phagocytes and are capa~le of cell division 
at the site of inflammation (5). 
Once the vascular and cellular events are activated, the 
process of "walling off" the inflammed area is initiated, The 
early isolation of the area probably is advantageous for it allows 
time for the phagocytic cells to assemble ~l the inflammed area. 












This obstruction, accompanied by the previously described vascular 
E 
< ... L 
g 
~ stasis, is responsible for one of the classic symptoms of inflam-
tr 
--
,... mation -- edema (1). 
_:j 
The inflammatory process, as described up to this point, has 
;-; 
g: 
been termed the "exudative degenerative" stage of inflammation. 
As this phase is terminated (by processes that are not Hell under-
stood), the final stage of inflammation characterized by fib!""r.._.o..,_.u..,.s..____ _______ _ 
tissue growth is begun (1). 
Connective Tissue Proliferation, The primary stimulus Hhich initiates 
new connective tissue synthesis at the inflammatory site is not yet 
knoHn, It is knmm, hoHever, that the repair process begins as 
a proliferation of fibrobl:::~.st.s and multiplication of small blood 
vessels by mitosis of connective tissue and endothelial cells. 
As the cellular proliferation penetrates the exudate, it produces 
a highly vascularized, reddish mass termed granulation tissue. 
Eventually, this granulation tissue completely replaces the exu-
date. The amotmt of fibrous tissue growth is dependent on the type 
of inflammation. Both acute and chronic inflammatory injuries 
follow similar patterns of tissue repair, but quantitatively larger 
amounts of fibrous tissue are formed in the course of tissue healing 
following chronic inflammatory processes (1). This stage of the 
inflammatory process, like the other stages that have been 
discussed previously, is subject to loss of homeostatic control. 
The formation of excessive fibrous tissue can lead to severe 
complications, and such a loss of control is one of the symptoms 
of rheumatoid arthritis (1). 
Research Rationale. The preceding description of the inflammatory 
process is brief and simplistic, but it is important because it 
points out that there are many potential ways whereby a pharmacologic 
agent might exert its effects in the treatment of inflammatory dis-
orders. For example, a pharmacologic agent could modify the inflam-
matory process by (1) affecting the etiological factors (i.e., the 
primary causes); (ii) affecting the mediators of the initial tissue 
injury whlch are ·.released by, or produced in response to, the 
etiological factors, and (iii) affecting the normal and/or abnormal 
processes which are evoked by the tissue injury in an attempt to 
restore function. Hhile inflammation per se has been defined 
sufficiently to permit a rational approach to the search for 
drugs to·modify its processes, satisfactory ani~ models for 
studying inflammation are not available. For example, the widely 
used carrageenin-induced pedal edema system in rats used to induce 
acute inflammation for drug screening of "anti-inflammatory" drugs 
often turns up false positives (17). Carrageenin is an agar-
like carbohydrate polymer from the Irish Moss plant: Chondrus 
crispus (Linne) Stackhouse (Gigartinaceae). Carrageenin is 
considered to be a sulfuric acid ester of a complex galactose 
polysaccharide (18). 
The present program of research, therefore, was designed to 
attempt to gain new insights into the possible etiology of inflam-
matory states -- for when new information concerning the etiology 
of these disease states becomes available, more: meaningful screening 
procedures for anti-inflammatory drugs will certainly be devised. 
Two preliminary studies have been published (19, 20), 






of fungi, yeasts, and certain microorganisms (21). Therefore, 
one might predict that any bacterial or fungal invasion could leave 
behind undegraded chitin or partially-degraded chitin as a permanent 
resident in the host tissue. While the immune response, phagocytosis, 
enzymatic catabolism or other defense mechanisms could destroy the 
causative organism, chemically resistant chitin could be left behind. 
This residue, being foreign to the body, could initiate and perpetuate 
residues would be effectively invisible to most detection methods (22). 
No living organism has ever been found in the lesions of rheumatoid 
arthritis. 
Chitin also occurs rather widely throughout the animal 
kingdom, especially in the connective tissue of invertebrates. (23). 
Its chemical nature has been studied extensively, and it has been 
identified as a polymer of N-acetylglucosamine more specifically, 
the carbohydrate moeity has been identified as the B, 1-4 linked 
polymer of N-acetylglucosamine (24, 25). See Figure A. Futhermore, 
it has been noted that the chitin seems to be aggregated to various 
proteins in the connective tissue of the invertabrates -- the individual 
proteins being dependent upon the particular species of invertebrate (23). 
The protein which is connected to the chitin is important since it 
seems to protect it from chitinase and chitobiase (26). 
With the above in mind, this study was directed towards 
determining whether or not various types of chitinous materials 
were indeed capable of inducing an inflammatory response upon 
injection. Secondarily, by the use of known anti-inflammatory 
drugs, this study was also directed toward determining the possible 
10 











mechanism(s) of action by which these chitinous materials could 
induce inflammation. 
The various chitinous materials studied include the following: 
(!) float material of Velella lata ( a pi.gmented jelly fish commonly 
known as the purple sailor and frequently found washed up on California 
beaches), ( ii) gladius or pen material of Loligo Qpalescens ( a common 
squid found in Pacific coastal waters), and finally (iii) the shell 
material of the common shrimp. Polyglucose (from cotton) Has also 
~-----inve-stigatea-.-carrageenin was used as a reference control. 
The ability of invertebrate connective tissue to cause an 
inflammatory response in mammals raises intriging chemical questions. 
The answers to these questions are hidden in the organization of 
the interacting moieties. For this reason, deproteinated ru1d 
partly deacetylated forms of the above mentioned chitinous 
materials were also studied for their respective phlogistic potentials. 
Since the natural forms consist of the chitin carbohydrate 
moiety (poly N-acetylglucosamine) and its corresponding protein, 
these natural forms may be considered true glycoproteins. The 
deproteinated forms consist only of the carbohydrate moiety, 
poly li- acetylglucosamine, while the partly deacetylated forms 
largely consist of glucosamine (27). 
Investigation into the potential phlogistic capacity of these 
forms should allow one to narrow the inflammatory moeity doHn until 
the minimum molecule(s) necessary for inducing the inflammatory 
response has (have) been isolated. i·~·· one should be able to 
define the tYPe of inflammation induced by the natural chitin-
based glycoproteins and to determine whether or not it is the 
participation of the glycoprotein complex, the carbohydrate 
13 
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moiety alone, or of the protein alone which is responsible for 
the induction of the inflammatory response. 
This research should add to our knowledge about the etiology of 
the inflammatory diseases of connective tissue. To date, the failure 
to detect a causative organism or chemical activator for such 
diseases has severely hindered effeorts to either prevent the 
initiation of such disease states or to effectively alleviate the 
clinical effects that these disease states produce. If the exact 
--~-----------------
chemical species triggering the inflammation could be determined, 
this could be significant in opening new avenues for drug treatment 
and design. 
MATERIALS AND METHODS 
Rat pedal edema assays: 
a Male Sp:rague-Dawley rats- weighing betueen 125 and 15_Q_g~ra._..ms......._ _____ _ 
were used, Upon arrival at our facilities, the animals were ran-
domized, marked, and assigned to experimental groups; each group 
consisting of from seven to ten animals. Animals were housed 
in pairs in cages with the following dimensions: 24.1 x 17.8 x 
17.8 em, The cages were made of galvinized sheet metal sides and 
wire-mesh floors. The environmental temperature was maintained 
0 at 72-75 C and the quarters were illuminated from 7 a.m. to 5 p.m. 
daily to simulate diurnal patterns. Block-type lab chovrb (placed 
on the cage floors) and tap water (bottles attached to the cages) 
were supplied ad libitum. All animals were housed under these 
conditions for at least one week prior to testing. 
At 0 hr., the animals were weighed, injected with sodium 
pentobarbitalc (30 mg./5 ml./kg. intraperitoneally) and then given a sub--
plantar injection of one of the test phlogistic agents. This injection 
a- Horton Laboratories Inc., Oakland, California. 
b - Purina Laboratory Chow. Crude protein not less than 23.0%; crude 
fat not less than 4.5%; crude fiber not more than 6.~~; and ash 
not more than 9.0% 
c -Robinson Laboratories Inc., San Francisco, California; 






was made into the animal's right hind paw using a 5/8-inch, 25-gauge 
a b needle,- and a micrometer syringe,- The legs of each animal were 
marked at the ankle joint using a permanent-type felt-tipped marker 
and all paw volumes were recorded plethysmographically to this point 
at -5 min,, +5 min., +1 hr., +3 hr., +5 hr., and daily thereafter 
through +20 days, 
The apparatus used for recording paw volumes consisted of a 
cylindrical plastic reservoir (approximately 25 ml. in volume) 
----------------------
filled with mercury and connected by an S-shaped glass tube (4 mm. 
I.D.) to a Statham Physiological Pressure Transducer,~ Model P23BB 
(Serial #14799) filled with distilled water. Volume changes in 
the mercury reservoir due to the presence of an immersed object could 
then be measured as pressure changes. These changes Here modified 
by the transducer into electric signals which were then amplified 
and recorded on heat-sensitive graph paper by a Beck~~ DynogTaph 
(Type RS)g equipped with a hot-wire stylus (see addendum A). 
Calibration of volume changes was accomplished by immersing 
a cylindrical Perspex rod attached to a stereotaxic unit (Narishiga 
#2321) into the mercury reservoir. Each calibration mark on the rod 
was calibrated to displace 0.5 ml. of water, and the Dynograph 'rlas 
calibrated so that the recording stylus correspondingly would move 5 mm. 
o~ the recording paper for each mark. Plethysmographic determinations 
of rat paH volumes Here not attempted until a linear displacement 
a- Becton, Dickinson & Co., Rutherford, New Jersey 
hyperchrome stainless hypodermic needle with regular point. 
b - RGI Inc. , Vineland, New Jersey. 
c -Manufactured by Statham Lnboratories, Inc., Hato Rey, Puerto Rico, 
d - The Beckman Dynograph (type RS) used was manufactured qy Beckman 
Instruments, Inc., Schiller Park, Illinois. 
by successive immersions of the rod at varying depths into the 
mercury had been demonstrated (28), 
The animals were held loosely ~-rhile the injected and then the 
contralateral paH volumes were recorded, This could be accomplished 
qy fully extending the legs by exerting pressure just above the Imee, 
A total of three immersions vrere used to determine the average paw 
volume of each rat at each time period. 
Degree of edema vras calculated by subtracting the control paH 
volume ttaken immediately before phlogiston injection) from the 
inflammed paw volume, and by computing the mean and standard error 
for each group. Statistically significant differences between groups 
were documented using Student's t test. 
The. follm-ring materials vrere studied for their phlogistic 
capacities: !1ycobacterium butyricum,~ carrageenin,& cotton,£ and the 
whole, deacetylated, and deproteinated forms of the float material of 
Velella lata,£ the gladius or pen material of Loligo opalescens,£ and 
the shell material of the common shrimp.£ All materials were ground 
to 200-mesh poHders before being suspended in either light mineral 
oil~ at a concentration of 5 mg./ml. and injected at a volume of 
0.05 ml., or in 0.9% saline§. at a concentration of 10 mg./ml. and 
injected at a volume of 0.10 ml. 
Short term single-dose drug studies: 
f Male Sprague-DaHley rats- Heighing between 125 and 150 grams 
a - Difco Laboratories, Detroit, Michigan; Catalogue #0640-25. 
b- Seaplant Chemical Corporation, NeH Bedford, Mass.; Seakem Type I 
Lot #312503. 
c -Received from R.L. Gainey, Chief Chemist, FMC Corp., Modesto, Calif. 
d - Light mineral oil N .F. 
e- Fisher Scientific Co., Fair Lawn, New Jersey. Biological Grade, 
Lot #73JI~OO. 
f- Horton Laboratories Inc., Oakland, California. 
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were maintai.ned as in the rat pedal edema assays. At -1 hr., the animals 
were taken off food, weighed, and dosed orally with either a 0,25% agar 
solution or <m anti-inflammatory drug suspended in a 0.25% agar vehicle, 
using an 18-guage oral feeding needle. At 0 hr., a 0.10-ml. subplantar 
a b injection of either carrageenin- or whole Velella float-- material (sus-
pended at 10 mg./ml. in 0.9% saline) was made into the right hind paw 
of the animals using a 5/8-inch, 25-gauge needle~ and a 2-ml. micro-
meter syringe·fL After phlogiston injection, food was again allowed 
----------:ad-~~bitum-.--Paw-volume-measurements-were recorded-at-~5-m~i-.,-+5-min~.~,-----------
+1 hr., +3 hr., and -tj hr. All animals were injected with sodium pento-
barbital~-30 mg./5 ml./kg. IP in order to insure precise subplantar 
pedal injections. 
The following drugs were studied for their ability to inhibit inflam-
mation induced by either carrageenin or whole velella float materials: 
f h i . . 
aspirin,- hydrocortisone ,-€£. cryogenine ,- phenylbutazone,·- indomethacin,}.. 
and chlorpromazine.k All of these drugs were suspended by trituration in 
1 -
0.25% agar,- and administered at a constant dosage volume of 10 ml./kg. 
a- Seaplant. Chemical Corporation, New Bedford, Mass.; Seakem Type I, 
Lot #312503. 
b Received from F.L. Gainey, Chief Chemist, FMC Corp., Modesto, Calif. 
c- Becton, Dickinson, & Co., Rutherford, New Jersey; hyperchrome 
stainless hypodermic needle with regular point. 
d - RGI Inc. , Vineland, New Jersey. 
e- Robinson Laboratories Iric., San Francisco, California; 
Sodium pentobarbital powder, U.S.P. Catalog #0140-01, Control 
#SC8403. 
f - Mallincdrodt Chemical 'lvorks, St. Louis Missouri. 
g -Nutritional Biochemical Corporation, Hollywood, Calif.; Control #2912. 
h - Compliments of William Hatson who isolated the cryogenine from Heimia 
salicifolia, using the procedure of Stanley T. Omaye (29). 
i Ciba Pharmaceutical Co., Summit, New Jersey. 
j - Merck, Sharp, & Dohme Research Lab, Rahway, New Jersey. 
k - Smith, Kline, & French Laboratories, Philadelphia, Pennsylvania. 
1 - Difco Laboratories, Detroit, Michigan; Difco Bacto Agar, Lot #0140-01. 
The amount of protection provided by each of the drug treatments 
against inflammation induced by either carrageenin or vrhole velella 
float material vias determined by subtracting the control paw volume 
(!·~·· the -5 min. reading which was taken prior to the injection 
of the phlogiston) from the inflammed pa~1 volumes, and by computing 
the mean and standard error for each group. Statistically signifi-
cant differences betr~een treatments was determined by use of 
Student's i test. 
MYCObacterium butyricum adjuvant preparation: 
The methods used in this preparation procedure were essentially 
the same as those described by Kosersky (30), One hundred n~. of heat-
killed desiccated r<Lycobacterium butyricum§; was triturated in a glass 
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mortar with light mineral oil N.F., to a final concentration of 5 mg./~l. 
This suspension Has then more finely divided and uniformly suspended 
by using a tissue homogenizer and pestleh fitted to an electric 
c motor- and spun at approxlrnately 1500 R.P.M. The pestle was moved 
up and dmm about 10 times. The adjuvant Has poured into 10-ml. 
parenteral vials, covered Hith rubber serum caps, and autoclaved 
at 120°F, 20 p.s.i, for 20 min. The adjuvant was then stored 
0 at 4 C for a week prior to use. Before injection into animals, the 
adjuvant Has warmed to room temperature. 
Chemical preparation of chitinous phlogistons: 
Whole, deacetylated and deproteinated forms of the floats 
a- Difco Laboratories, Detroit, Michigan. Catalog number 0640-25. 
b- Kontes Glass Co., Vineland, New Jersey. Kontes glass jacketed 
tissue homogenizer, mortar #71, pestle #52. 
c- Talboys Engineering Corp., Emerson, NeH Jersey, model lo6. 
p 
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of Velella lata, of the gladius cr pen material of Loligo opalescens, 
and of the shells of the common shrimp, were prepared by Ralph L. 
a Gainey- in the following manner: Natural whole floats of the 
b Northern California variety of Velella lata- Here dried and freed 
of sand and extraneous materials. Gainey has documented that the 
floats are approximately J,O - 4.0% inorganic material, 0.2 - O.J% 
lipid, 55.0 - 58.0% carbohydrate, and 42.0 - 45.0% protein by 
dry Height (31), The samples of natural whole float material that 
-
!-----were received were labelled K-749000 and RG: 740405A. Deacetylated 
Velella lat~ was prepared by allowing the dried, washed floats to 
set for 36 hrs. in 6N KOH folloHed by neutralization and washing. 
The samples of deacetylated vel~lla that were received were 
labelled.K-749005 and RG:740405B. De~roteinated Velella lata 
was prepared by alloHing the dried washed floats to set for 8 days 
in 6N KOH at room temperature followed by subsequent neutralization, 
washing, and drying. The sample of deproteinated velella that Has 
received was labelled FG:7J0621. 
The whole gladius or pen material of Loligo opalescens was 
prepared by washing and drying the chitinous pens, '!he pens were 
then diced and ground in a Spex grinder for 2-3 min. to a fine 
powder. This powder was placed in a 250-ml. erlenmeyer flask with 
100 ml. 6N KOH at room temperature (22°C) for 11 days. After 11 
days the material was filtered and washed a number of times with 
deionized water, folloHed by a wash with 0.5 M HCl and several 
more washings Hith deionized water. Three washings of acetone 
a- R.L. Gainey, Chief Chemist, FMC Corp., MOdesto, California. 
b - Velella lata: Phylum: Coelenterata; Class: Hydrozoa; 
Order: Hydroida; Suborder: Chondrophors. 
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were used to promote drying and the material was placed in the oven 
0 for 10 min. at 110 C. The sample of whole loligo pen material 
which was received was labelled #139-2. Deacetylated loligo pen 
material r1as prepared by taking ordinary pen material and washing 
it in water upon removal from the animal. It was then dried in 
air at room temperature and ground in a Spex grinder to a fine 
powder. The powder was washed 3X with 0.5 N HCl (to remove 
residual iron) and then washed 3X with acetone (to aid drying). 
It was stored for less than four weeks in a glass vial at room 
temperature and then boiled in JN KOH for 25 hrs. It was then 
washed 3X rrith 0. 5 N HCl and finally 3X with acetone and placed 
in a glass vial'which was labelled RG:740715 upon receipt. 
Deproteinated loligo pen material was prepared by placing cleaned 
dried whole pen material in a 25-ml. flask and covering it uith 
6 N KOH. After 9 days at room temperature, the pen material was 
.filtered and washed with water until the filtrate no longer gave 
a pL~k color to a phenolphthalein solution. It was washed lX with 
0.5 N HCl and 2X with acetone. A final wash with water was 
followed by drying at 110°C for 10 minutes. The sample of depro-
teinated loligo pen material that was received was labelled #152-B. 
Whole shrimp shell material was prepared by washing the shells 
of fresh shrimp to free them of adherent material, and by drying 
them at room temperature. The shells were ground in a Spex grinder 
for 3 minutes. The ground shells were transferred into a sintered 
glass filter and washed 2X with 0.5 N HCl, 2X with acetone, and 
0 dried at 110 for 20 minutes. The sample of whole shrimp that 
was received was labelled #152-A. Deacetylated shrimp shell 
material was prepared by allowing the dried washed whole shells 
0 to set for 24 hrs. in 1N KOH at 110 C. The sample of deacetylated 
shrimp that was received rlas labelled RG·: 740225. Deproteinated 
shrimp shell material was prepared by washing and drying the shells 
of fresh shrimp (identical to sample 1/152-A). These shells were 
then placed in 6N KOH for ten days at room temperature after bei.ng 
washed with 0.5N HCl and acetone, The deproteinated shells were 
washed on a sintered glass filter until the filtrate faHed to give 
color to a phenolphthalein solution, indicating base removal. After 
wasning Jx-wrth acetone,--the shell material was dried for 10 min. 
at 110°C and placed on a Mettler LP 11 drying balance and brought 
to a constant weight. The sample of deproteinated material was 
labelled #152-C. 
All treated or untreated chitinous materials discussed in this 
section were ground to 200-mesh powders before they were suspended 
in either agar or 0.9% saline. 
Chemical preparation of cotton: 
Common Johnson and Johnson cotton was boiled in JN KOH for 
24 hrs. and then washed to neutrality 1-dth distiJ.led water. Any 
dark specks were removed with forceps after drying in acetone/air 
at room temperature. The dry fibers were chopped with scissors to 
lengths of 1 em. or less and placed in a Spex grinder for 10 min. 
The powdered cellulose was slurried with 0.5N HCl for a few seconds 
and then vacuum-filtered through a sintered glass filter to remove 
traces of iron. The cellulose was washed on the filter 2X with 
0.5N HCl and JX with distilled water, It was then, washec JX with 
acetone and left on the filter J-4 min, to dry, The fine white 
powder was then transferred into a small vial which was labelled 
~-
~= 
RG:74o617 upon receipt.~ 
Chitinous phlogiston suspension (in light mineral oil) 
One hundred mg. each of the floats of whole velella, deacetylated 
velella, and deproteinated velella (all ground to 200-mesh powders) 
were triturated separately in a glass mortar with light mineral oil 
N.F., to a final concentration of 5 mg./ml. These suspensions were 
then more finely divided and uniformly suspended by using a tissue 
,-----homogenizer-and-pestle'!? f'-i-tted--tO-a.YJ.-electr-ic-motoJ;~ and-s:pu.YJ.-at 
approximately 1500 RPM. These preparations were then poured into 
10-ml parenteral vials, covered with rubber serum caps, and stored 
at 4°c for one week prior to use. Before injection into animals, 
these preparations were warmed to room temperature. 
Chi tin and cotton phlogiston suspensions (in saline): 
One hundred mg. each of the whole, deacetylat.ed, and deprot.einated 
materials derived from the floa.ts of Velella lata, from the pen 
material of Loligo opalescens, and from the shells of the common 
shrimp, and 100 mg. of cotton (all gr,ound to 200 mesh powders) 
were placed separately in a 10·-ml. graduate cylinder and suspended 
in 0.9% saline to a final concentration of 10 mg./ml. These suspen-
sions were then transferred into tissue homogenizers with pestles 
fitted to an electric motor and spun at 1500 R.P.M. When uniform 
suspensions were achieved the preparations were transferred to 10-ml. 
parenteral vials with rubber serum caps and stored at 4°c for one 
a- R.L. Gainey, Chief Chemist, FMC Corp., Modesto, California. 
b- Kontes Glass Co., Vineland, New Jersey, Kontes glass jacketed 
tissue homogenizer. 
c- Talboys Engineering Corp., Emerson, New Jersey, model lo6. 
2) 
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week prior to use. Before injection into animals these preparations 
were warmed to room temperature. 
Drug preparation and suspension: 
a All drugs were suspended by trituration in 0.25% agar- and 
administered orally using a constant 10 ml/kg. dosage volume. 
Preparation of drug suspension and storage conditions were as 
follows: aspi:r:inE, JOO mg./kg., hydrocortisone alcohol£, 20 mg./kg., 
phenylbutazone,£ 100 mg./kg., indomethacin,~ 10 mg./kg., and 
chlorpromazine,! 100 mg./kg, These solution-suspensions were prepared 
three days prior to use and stored at 4°C. Cryogenine~ suspension, 
100 mg./kg. was made immediately prior to use. All drugs were warmed 
to room temperature before being administered to the animals. 
a Difco laboratories, Detroit, r1ichigan; Catalogue #0140-01. 
b Mallinckrodt Chemical Vlorks, St. Louis, Missouri. 
c - Nutritional Biochemical Corp. Hollywood, Florida; Control #2912. 
d Ciba Pharmaceutical Co., Summit, New Jersey; lot #SN52?J. 
e - Merck, Sharp, & Dohme Research Lab., Rahway, New Jersey; 
lot # l-590226-00A104. 
f- Smith, Kline, & French Lab., Philadelphia, Pennsylvania. 
g - Compliments of Hilliam Watson (28). 
RESULTS 
Rat pedal edema assays: 
The initial study was performed in order t.o determine whether or 
not velella materials were capable of inducing an inflammatory 
response; and if so, whether this response was similar to that 
induced by mycobacterium adjuvant. Since killed MycobacteriD;!!} 
butyricum (administered in light mineral oil and inJected pedally 
in rats) induces a chronic long term polyarthritis, v;hich is appar-
ently immunologic in nature (30), all velella materials were 
likewise suspended in iight mineral oil. Futhermore, each of 
the velella materials was studied at levels identical (mg. for mg.) 
to those widely used for inducing inflammation with Hycobacterium 
butyricum. 
When MyCObacterium butyricum was suspended in light mineral 
oil and injected pedally into rats, it produced a statistically 
significant amount of swelling in the injeGted paw when compared 
to the injected paws of animals receiving only the light mineral 
oil vehicle control. This swelling began at +1 day and persisted 
through the 20-day observation period, and was statistically 
significant from the vehicle control at a probability of p 0.001 
(see Table I). Whole velella float material and partly deacetylated 
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Table I: Tv1ean injected pa;; volumes of rats vith adjuva.."lt-induced inflainr:tation or velella-i.11duced 
inflc.!TII!'.a tion (phlogiston vehicle: light mineral oil) 
I 
Change from +5 min. volume, jll• (! 1 SEM) 
+5 min. -r 




+0.18 Light mineral oil 2.09 -0.09 +0.12 -,r-0.06 +0.17 
vehicle control (0.02) (0.05) (0.05) (0.04) (0.05) (0.07) 
rt;ycobacterium adjuvarlt 8 2.06 -0.07 +0.06 
c 
Jl.72£ +1.91£ c +1.17- +1.81-
(O.Oi+) (0.05) (0.02) 
I, 




+0.26 ~~ole velella float 8 1.97 -O.OG +0.05- +0.19 +0.22 +0.19 
material (O.OJ) (0.03) (0.09) ~.o.c6) (0.02) (0.06) 
b 1- +0.32~ 
I 
Partly deacetylated 8 1.98 +0.11~ 
, a 
+0.23 +0.07- +0.23- +0.21 
velella float materia.l ( 0. OL~) (O.OL:.) (0.07) 0,0.07) (O.OJ) (0.05) 
I 
' 
Denroteinated velella 8 2.00 -0.11 +0.00 +0.15 ~-0.13 +0.17 +0.17 
float rr2.terial ( o. o;~) (O.OJ) (0.02) Q0.07) (0.06) (0.06) 
I 
I 
~. E., and £ indic.:de :2. ( 0. 05, :2. < 0. 01, anr' 12 < 0. 001, resrlectively. Fdr all oU,er values, 
E > 0.05. 
~ 
0 
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Table I continued. 
Change from +5. nj_n. volume, ml. (%- 1 SE!·i) 
+5 cl. -t6 ci. +7 d. +8 d. +9 d. 
Light mineral oil +0.20 
~ 
+0.13 +0.12 +0.15 -0.01 
vehicle control (0.05) (0.05) ( 0. OL~-) (0.0.5) (0.00) 
!-~ycor.JC.cterium adjuvant +1.'30~ ''2C 
. nC +1.50~ 1 00~ +l.o _- +1,1-i-c,- + .r_ 
(0.20) (0.20) ( 0.21) (0.21.!-) (0.25) 
':-Ihole velella float +O.l'l +0.10 +0.11.;- +0.17 +0 .122 
rr.aterial (0.06) (o.o6) (0.02) (0.07) ( 0. 02) 
Partly deacet:/lated +0.23 +0.19 +0.13 +0 ,1(3 +0.14 
velella floa.t !T'.a.terial (0.05) (0.02) (0.05) I I ' (0.07) \.. 0. 0·-~) 
Deproteinated ve1e11a +0.11 +0.09 +0 .lL~. +0.07 +0.12 
float mz.teTia1 (0.05) (0.06) (0.03) (0. 06) (0.05) 
- b ~ 
::, -·, ancJ =--- i.r.c'.icate p < 0.05, 2 .( 0.01, and 1) ( 0.001, respectively. 
:£ > 0 .0). - -
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+11 cL +12 d. 
-0.01 +0.02 
(0.04) (0.05) 
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Table I continued. 
Change from +5 min. vclume, 1d. ( 1 SEH) 
Light mineral oil 
vehicle control 
Eycobacterium adjuvant 
';fhole velella float 
r~aterial 
Partly deacetylated 
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velella float material also produced some swelling in the injected 
paws which was statistically differnt from the control, but the 
time-sequence of the swelling did not appear to follow any consistent 
pattern. Futhermore, the swelling produced by both materials was 
only about one-sixth that produced by the Mycobacterium butyricum 
(see Table I and Figures 1-2), Deproteinated velella float material 
did not produce any statistically significant degree of swelling 
(see Table I and Figure 3). There was no evidence of the slow onset 
of polyarthritis in the contralateral paws of animals injected with 
\ 
velella materials as was seen in those animals receiving the myco-
bacterium adjuvant (see Table II and Figures 4-6), 
The results shown in Tables III and IV, and in Figures 7-13, 
are from a study which was performed in order to determine whether 
or not the velella materials were capable of producing an acute, 
short-term inflammation similar to that produced by carrageenin (31). 
Therefore, all velella materials, like carrageenin, were suspended in 
0.9% saline and studied at levels identical (mg. for mg.) to those 
widely used for inducing inflammation with carrageenin (31). 
~fuen carrageenin was suspended in 0.~1, saline and injected 
pedally into rats, it produced a rapid-onset, short-term inflammation 
in the injected paw as expected. A peak in swelling was reached 
at +3 hr., which was statistically significantly different from the 
saline vehicle control at a probability level of g(O.OOl. This 
swelling disappeared and was no longer statistically significantly 
different from the saline vehicle control by +1 day (see Table III). 
The velella rraterials, when suspended in 0.9% saline, also produced 
a rapid onset, carrageenin-like inflammation, but this inflammation 




in the injected pavrs of animals by mycobacterium 
adjuvant and. vlhole velella float material. 
(phlogiston vehicle: light mineral oil) 
Values indicate change from +5 min. volume, Ill~. 
mycobacterium adjuvant 
II whole velella float material. 
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Fig. 2 -- A comparison of the types of inflam~tion induced 
in the ~ject~ pavrs of animals by mycobacterium 
adjuvant and partly deacetylated velella float 
material. 
(phlogiston vehicle: light mineral oil) 
Values lnclicate change from +5 min. volume, ml. 
8 mycobacterium adjuvant 
IJ partly deacetylated velella 
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Fig. 3 -- A comparison of the types of inflamnntion induced 
-----
in the injected paHs of animals by mycobacterium 
adjuvant and deproteinated velella float material. 
(phlogiston vehicle: light mine~tl oil) 
'.'alues indica.te change from +5 min. volume, ml. 
• m:rcobacterium ad.jw.rffl.t 
tl1 deproteinated velella 
0 light mL."leral oil control 
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Table II: nean contralateral pa1·: volumes of rats Hith adjuvant-induced I inflammation or velella-
induced inflamrnation (phlogj_ston vehicle: light mineral oil) 
Change £rom +5 min. volume, 
+5 min. 
'( 
'· volume, ml. +1 hr. +3 hr. +1 d. 
Light mi_r:teral oil 8 1.88 -0.01 -O.OJ +0.05 
vehicle control (0.03) (0.05) ( 0 0' \ ' Lt-) 
J'tycobacterium adjuvant 8 1.87 -0.08 -0.03 -0.09 
( 0. OL~) (0.05) (0.09) 
~!hole velella float ~3 1.77 -0.06 -0.01 +O.OS 
mc.terial (O.Oh) (0.03) (0.06) 
?artly deacet:rlated 8 1. 7L'r a +0.09- +0.05 +0.03 
velella float r..aterial ( 0. Ol;) (0.05) ( o. ot:.) 
De:r.;roteinated velella 8 1.75 +0.03 +0.00 +0.01 
float rr:.c.terial (o.o<.:-) (0.02) (O.OJ) 
ihc~:_icatc :2 < 0. 0_5' E.< 0. 01' anc. ·r; < 0.001, rec_;!'ectivel:;. a b , and 
c 
2> 0.05. 
'lmi1Jinmirl~~: I 1111:1..: ' I: 
J:,JJ,j 
!I 
~1. (± 1 SEM) 
I " , +.::: Q. 
I 
+3 d .. +4 cL 
I 
+o.o6 +0.10 +0.00 
~O.OJ) (0.03) (0.05) 




+o.oo +0.05 -o.o4 
~ 0 0/ \ . . c J 
I 
(0.03) ( o. 06) 
J.n or. 
'I ....... • ..,_.. +0.12 +0.06 
(0 .07) (0.03) (0.06) 
I 
I a 
+0.11 +0.07 ·tO .11-
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Table II continued. 
Light mineral oil 
vehicle control 
:-'ycobacterium. adjuvant 
Khole velella float 
material 
Partl:r deacetylated 
velella float m.ate:t·ial 
Deproteinc.teo_ velella 
float r.a.terial 




















( 0. Oi~) 
+0.09 
(0.03) 
8. c , a~c: 
' 
c . '. t ·- lnO.lC2: 8 E < 0.05, 2 < 0.01, CLY}·rl 
E> o.os. 
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+3 d. 
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Table II continued. 
Change from +5 min. volume, ml. ( 1 SET·;) 
+13 d. +1'-;- d. +15 c1. +16 d.. +17 d. 
Light mineral oil -0.04 -0.03 +0.01 -0.01 +0.00 
vehicle control (0.04) (0.06) (0.03) (0.06) (0.03) 
'i"ycobacterium adjuva~1t · -0.01 +0.03 +0.15 +0.38 +0.43 
(0.03) ( 0. Ql;.) (0.12) (0.20) (0.27) 
'lhole velella float +0.10 +0.02. +0.09 +0.05 +0.03 
material (0.05) (0.05) (0.03) (0.05) ( 0. 0~~) 
Pa.:rt1y deacetylc.ted +0.10 +0.11 +0.13 +0.10 +0.13 
velella float ne.terial (o·.o5), (0.06) (0.05) (0.05) (O.OL;.) 
~eproteinated velella +0.10 +0.09 +0.12 +0.11 +0.13 
float 111.a.terial (0.05) (0.05) ( 0. ()!.;.) (0.04) (0.04) 
~; ~. anrl_ ~indicate p ( 0.05, ;) <. 0.01, and 11 <. O.UOl, respectively. - - ~ 
E) 0.05. 
·'lli'lmm!]""l'rrr~l"' , nllll:ll!!lllll 11 1111,11 1 '!I':~..: 1.1.. I 1::11, !I 
I 
il n , .,, () a . +19. d. +20 d . 





1·0.90- +0.82~ +0.7L!. 
QO ~h) (0.33) (O.Jl) .. _..' 
~·0.08 +0.10~ +0.08 
~0.05) (0.03) (0.31) 
! b 
+0.06 ~·0 .15- +0.09 
CO. OL:.) ( 0. 06) (0.05) 
I a 
+0 .09~ +0.14~ -+1o .10-en ,,, \ (0.05) (0.04) ; ... , • u---; 
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Fig. 4 -- A comparison of the types of inflamrnat1on incluced 
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0 
adjuvant ancl vrhole velella float material. 
(phlogiston vehicle': light mineral oil) 
Values indic_ate change from +.5 min. volume, ml. 
• mycobacterium adjuvant 
II Hhole velella float material 
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Fig . .5 -- A com}_)arison of the types of inflamr.ation induced 
0 
in tbe contra.late-r·al ;pa:,.rs_of-animals-by-mycobac-tez--ium, __ _ 
adjuvant a.'1d partly deacetylatecl velella float material. 
(phlogiston vehicle: light mineral oil) 
Values indica,te change from +5 min. volume, ml. 
8 mycobacterium adjuvant 
IJ partly deacetylated velella 
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Time After Pedal Injection 
Fig. 6 --· A ccmpexipon of the types of infla,mmation induced. 
in the contrctlateral pahs of animals by mycobacterium 
adjuvant and. deproteinated velella floe.t n-..ateri.al. 
(phloGiston vehicle: light mineral oil) 
Values indicate change from +5 min, volume, ml. 
0 mycobacterium ·adjuvCJ..nt 
[I deproteinated velella 
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Table III: r~1ean injectecl paw volumes of rats ldth carra.geenin-induced inflamrnation or velella-
induced inflamrr.a tion (phlogiston vehicle: 0, 9:· sc;;.line) 
Cha"lge from +5 min, volume, ml. ( ± 1SEM) 
+5 min. 
!·r volume, ml. +l hr. +J hr. +1 d. +2 d. +3d. +L~ d. 
0.~ Saline vehicle 8 1.82 +O.OJ -0.02 +0.10 -O.OJ -0.04 -0.12 
control (0.09) (O.OJ) ( 0. o.s) (o.oS) (0.04) (0.05) 
Carrageenin 8 1.9() +0.13 
c 
+0.72- +0.19 -0.01 +0.04 -0.05 
(0.07) (0.08) (0.06) ( 0. 04) (0.07) ( 0. ()1.;.) 
?bole velella float 8 2.01 -0.05 
b +0.20- +0.51:£ +0 .25E. +0 .2J£ +O.llE_ 
material (O.Oi.;) (o.o~) ( 0. 06) (0.03) (0.03) (O.OJ) 
Fartl:r deacetylated ,q 2.03 +0.011-
b 
+0.23- ~a +0 . ./"1- +0 .lL~ +0.10 +0.09~ 
velella float materia.l ( ~ / ' 0 .U:) (0.06) (0.09) ( 0 l'/ \ . ,c J (0.07) ( 0. 0·?) 
T'enroteinateo velella p 1 .C~Q +O.OJ +0.08 +0.29 +0.14 +0.10 +O,OP . / 
float Material (0.07) (O.OR) (o.os) (0.06) (0.09) (o.os) 
a b . 
' -, 2.nC . .£ i nrl · . r > o.o_s. --- .lcc:.-c.e 2 <. 0.05, p < 0.01, "'""1 -- / l_~, ... .:.\.i. J:) ' 0.001, respectively. For all otter values, 
llnmmrmnT~~U:T.I'llln:IVlllll ,; ·1 .I l .11.1.1 lllnT lr.I:··I'n11':"11'1r111TT1' 
+:" 
\.)'\ 
Table II~ continued. 
h +' t:; • 1 C"l (.i 1 ... ,I ' C ange .!.rom + ....- mut. vo urr:.e, TILL. ::J~_,/;) 
·+5 d. "' .I +:) c.. +?d. +n d. +9 d. +10 cl. +ll d. +12 d. 
0.9% Saline vehicle -0.11 0.09 -0.10 +0.02 -0.11 -0.07 -0.11 -0.01 
control ( 0, OL:.) ( 0. Qi_~) (G. 0:2) (0.09) (O.OJ) ( 0. 02) (O.OJ) (O.OJ) 
Carrageen in -0.01 +0.01 ·-0 .12 ·-0.09 - 0.01+ -0.12 -0.11 -0.07 
(0.02) (O.OJ) (0.03) (0.01) (0.03) (0.01) (0. CLr) ( 0. o~.c.) 
Hhole velella float +0 .122 +0.10~ +0 .lL)2 +0.10 +0.07 +0.06 +0.04~ +0.03 
... • 1 ma .. erla .... (O.OJ) (0.06) (0.09) (0.0(>) ( 0. 01+) (0.07) (0.09) (0.07) 
Fartl:r deacetylated +0.11!2 +0 ro~ +0 .11 E. +0.09 a +0.05 +O.OL~ +0.03 . ·'./ +0.09-
velella float rraterial (0.05) ( / \ 0. 0(; .I (0.05) (0.07) (0.08) ( 0. 0·.5) (0.05) (0.03) 
Deproteinated vele1la o oc;~ + . _, +0.09£ +0 ~ ')£ • ..L._ +0.10 +0.07 +0.05 +0.01~ +0.07 
float Ii'.r'l terial (0.05) ( 0. oc) (O.C7) ( 0. Q.C!) (0.07) (0.07) (0.05) (0.05) 
a b , c . ,. t / 0 ()"' -, -, ano - ll10 lCE1• e }-l , • .J, p ( 0. 01, anc~ p ( 0. 001, :::es:;:.ecti v ely. For all other values, 
r> 0.05. 
~ 
)llfiiiiWr- F':111mt'rr!i .I ~ I 1 I. I.: .. 1:: I.I!!IT :JJ::J:::.]j~ ;J::.-1[1. jf-l]l. 111: . : JL::.J:J;mnl : .. ~IItU:l' : :rr:J:.-J::rmrr:Jcrr·rr:rrrlllf"TI'r'rnr~·.,. ·1 "r· r·· · ........ Jrn·:, ··· ·I"Tn'" ~--
Table III continued. 
Change from +5 ;;)in. volur:J.e, ml. (* 1 S~rl) 
+13 d. +11~ d. +15 d. +16 d. +17 d. 
0. 9':. Saline vehicle . -0.10 -0. OL~ -O.OJ --0.07 -0. OLi 
control (0.04) (0.05) (0.05) ( 0. O!J-) (0.03) 
Carrageenin -O.OP -0.08 -0.02 -0.10 -0.07 
(0.05) (O.OJ) (0.03) (O.OL~) (O.OJ) 
Whole velella float +0.05 +0.07 +0.10 +0.07 +0.03 
material (0.07) (o.oc.) (0.05) (0.07) (0.06) 
2 +0.13 +O.O;S +O.lL!-£ 
c 
Fa:r·tly deacetylated. +0.05..:;. +0.15-
velella float material (0.05) (0.05) ( 0. 01~.) (O.Oh) (O.OJ) 
Deproteinated velella 
a +0.12 +0.07 +0 .12?:: 
a +0.10- +O.lL~-
float material (0.07) (o.oG) (0.05) (0.07) ( / \ o. Oc) 
~. Jl, and.£ ind.icate p < 0.05, :p <. O.OJ., ancl p <. 0.001, res11ectively. 
n) 0.05. -
r11lllllmll~": !lr!1llllrn':!rt ·; ! .I 1 Ll: LI!JjFJr.Il~.]~~-:J:::rl: )p!l .. nl: 
+H3 d. +19 ci. +20 d. 
-0.0:3 -0.08 +0.02 
(0.03) (O.OJ) (0.04) 
-0.08 -0.06 +0.01 
( 0. OL~) (O.OJ) ( 0. 06) 
+0.03 .+0.05 +0.07 
(0.05) (0.07) (0.05) 
+0.07£ +0.10?:: +0.04 
(0.05) (0.06) (0.06) 
a +0.08- 2 +0.10- +0.09 
(0.06) (0.06) (0.05) 
For all other va.lues, 
~ ..._, 
.II , ~1::~: :CJ:an:ll.': :!IIn:J: '-:"llii~T;;nTIIr:rrrr;··:nm:rrrnT~nTr··.-e-1-r r·····- ·· .. --~-, "'rm···-wrr·rr-·-, 
Table IV: !l;ean contralateral pa1·l volumes of rats i·ri th carrageenin-lhduced i..'1flarr1111ation or 
velella-inducecl inflamma.tion (phlogiston vehicle: 0. 9f, saline) 
Change from +5 min. volume, ml. (± 1SEM) 
+5 min. 
N volume, ml. +1 hr. +J hr. +l cl. +2 d. +3 d. +4 d. 
0. 9"' Saline vehicle 8 1.60 -0.02 +0.03 +0.20 +0.19 +0.13 +0.05 
control (O.Oh) (O.OJ) (0.03) (0.07) (0.02) (0.03) 
CaYrageenin 0 1.67 -0.03 +0.13 +0.13 +0.04 +O.o6 +0.04 
(O.OJ) ( 0. OL!-) (0.04) (0.05) (0.04) (0.03) 
;,:hole 'relella float 8 1.70 +0,00 +0.03 +0.14· +0.07 +0.13 -0.02 
material (0.05) (0.05) (0.05) (0.05) (O.OJ) (O.Oi.;.) 
Tartly cieacetylated 8 1.76 +O.Ol +0.10 +0.08 +0.13 +0.11 +0.10 
velella float material (O.OJ) (0.03) (0.05) (0.05) (0.07) (O.OLr) 
Deproteinated velella 8 1.63 +0.05 +0.10 +0.09 +0.10 +0.10 +0.0~ 
float material (o.o;) ( 0. 02) (0.05) (O.Ol.f) (0.06) (0.05) 
~. b., anr.J . .£ indice>.te n ( 0.05, Tl < 0.01, anc:. p < 0.001, respect::!.vel:v. For all other ",·alues, 
r> o.o5. 




Table n continued. 
Change from +5 min. volume, ml. (:!: 1 SBM) 
+5 d. +6 d. +7 r1, -rH d. +9 d. 
0. 9;~ Saline vehicle +0.08 +0.08 +0.08 +0.08 +0.07 
control (0.05) (O.OJ) (0.02) (O.OJ) (O.OL~) 
Carrageen in +0.07 +0.10 +0.03 +0.05 +0.10 
(0.01) (O.OL~) ( 0. 02) (O.OJ) (0.03) 
~mole velella float +0.07 +0.07 +0.05 +0.05 +0.11 
mate::cial ( 0. 02) ( I ' 0 0 0·!·) (0.05) (O.OJ) (0.05) 
Fartly deacetylated +0.13 +0.10 +0.13 +0.13 +0.15 
velell~ float material ( 0. Oi;-) ( 0 Oi• \ . '•() (0.05) (O.C3) (0.05) 
Deproteinated velella +0.11 +0.00. +0.12 +0.00 +0.07 
float material (O.OJ) (O.OJ) ( 0. Ol;.) (0.08) (0.04) 
a b -, -, 
~ 
an~ ~ indicate p ( 0.05, p ( 0.01, ar:d r < 0.001, 2:"8SJJecti vel~{. 
p > o.cs. 
ll1JIP.f!mP11JHP'-"111'1~J!PI1:!1! 1.1,' I r r 1 •• 1 •• : r r -: m::u:iJ,.:I: 11 ~ r,:::rl: . rr rrr .. niJ 
+10 d. +11 d. +12 d. 
+0.12 +0.08 +0.09 




(0.02) (O.OJ) (0.02) 
+0.08 +0.05 +0.06 
(0.04) ( 0. 06) (0.04) 
+0.1!.; +0.15 +0.13 
(0.05) (0.06) (O.OJ) 
+0.10 +0.09 +0.11..:.. 
(0.05) (0.04) (O.OL:-) 
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Table IV continued. 
Change from +5 min. volume, ml. (:t 1 ssr:) 
+lJ d. +14 d. +15 d. +16 d. +17 d. +18 d. +19 d. +20 d. 
0.~~ Saline vehicle +0.06 +0.12 +O.lJ +0.09 +0.15 +0.10 +0.10 +0.17 
control (O.OlJ-) ( 0. OIJ.) ( 0. 02) (0.04) (0.02) (0.03) (O.OJ) (0.03) 
Carrageenin +0.09 +0.10 +0.19 +0.09 +0.11 +0.04 +0.09 +0.18 
(0.03) (0.03) ( 0. OL~) (O.OL+) ( 0. OL'.) (0.02) (0.03) (0.06) 
~-!hole velella float +0.11 +0.10 +0.13 +0.13 +0.13 +0.10 +0.03 +0.14 
rnaterial (0.01+) ( 0. Ol+) (O.Oi~) (0.01~) (0.04) (0.06) (0.04) (O.OJ) 
Partly cleacetylated +0.17 +0 .llJ. +0.17 +0.18 +0.21 +0.11 +0.15 +0.15 
velella float nateria1 (0.05) (O.Oh) (0.05) (0.05) (0.01~) (0.03) (0.05) (o.o6) 
Deproteinatecl ve1e1la +0.11 +0.15 +0.10 +0 .14 +0.21 +O.lLl- +0.14 +0.15 
float material (o.o5) (0.05) ( () Qi..~) ( 0. Ol:.) ( 0. Ql!.) (0.05) (0.05) (0.04) \ _j. ' 
~. Q., and£ indicate p < 0.05, p ( 0.·01, and p (.·0.001, respectively·. For all other values, 
p > 0.05. 
., '"""~···· ""'~'"' . ,,. .... ~·-···-.. ··· -~-- .. ···········--·· 
\..n 
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Fig. 7 -- A comparison of the types of inflammation induced 
in the in.iected pal·ls of animals by carrageenin and 
Hhole velella float material. 
(phlogiston vehicle: 0.9% saline) 
Values i.YJ.dicate ch2nge from +.5 min. volume, ml. 
•• 
e carrageenin 
II v1hole velella float material 
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Fig, 8 -- A comparison of the types of inflammation induced 
in the ;in iected pat;s of animals by carrageenin and 
partly deacetylated velella float rr~terial. 
(phlogiston vehicle: 0. ~m saline) 
Values inc1icate change from +5 min. volume, ml • 
• carrageenin 
I) rieacetylated vel ella ... 
0 0 , 9% salirie 
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Fig. 9 -- A comparison of the types of inflammation induced 
in the. injected pav<s of animals by carrageenin and 
deproteinated velella float material. 
(phlogiston vehicle: 0. SP,Io saline) 
Values indicate c~ange from +5 min. volume, ml. 
8 carrageenin 
01 deproteinated velella 
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Fig. 10 -- A comparison of the types of inflammation induced 
in the injected paHs of animals by whole, deacetylated, 
and deproteinated velella. 
(phlogiston vehicle: O.~s saline) 
Values indicate change from +5 min. volume, ml. 
a 'Hhole velella 
DO deacetylated velella 
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Fig. 11 -- A comparison of the types of infla~~tion induced 
in the central atercd paHS of animals by carrageenin 
and -.rhole velella float material. 
(phlogiston vehicle: 0.9% saline) 
Values indicate change from +.5 min. volume, llll. 
(8 carrageenin 
II lihole velella 
0 0 . 9;':, saline 
0 
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Fig. 12 - -· A comparison of the types of inflammation induced 
in the contralateral pa1-:s of ani:mals by carrageenin 
and partly deacetylated velella material. 
(phlogiston vehicle: 0. 9;[. saline) 
Values indicate change from +.5 min. volume, ml • 
• carrageenin 
I] deacetylated vel ella 
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Fig. 13 -- A comparison of the types of inflammation induced 
in the cont:t'alateral pavrs of animals by carrageenin· ·· 
and deproteinated velella material. 
(phlogiston vehicle: 0.~~ saline) 
Values inciica te change from +5 min. volume, ml. 
8 carrageenin 
[I deproteinated velella 
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inflammation persisted (unlike carrageenin) through the +20 day 
observation period (see Table II and Figures 7-9). On an equal 
weight basis and considering the +1 to +2 day readings, the velella 
materials can be ranked in ascending order of their phlogistic 
capacity: deproteinated, deacetylated, and whole velella float 
material (see Figure 10). Like carrageenin, when the velella 
materials were suspended in 0.9% saline and injected, there was 
no evidence of the swelling or of secondary lesions in the contra-
lateral paws characteristically associated with the onset of 
Mycobacterium butyricum adjuvant polyarthritis (see Table IV 
and Figures 11-13). 
The results shown in Tables V and VI and in Figures 14-15 are 
from a study which was performed in order to attempt to reproduce 
the results which were obtained in the last study. Since de-
proteinated velella float material did not seem to possess significant 
phlogistic capacity, it Has elimated from this study. Readings 
were also conducted at certain time intervals not covered in the 
preceeding study (-.5 min. and +5 hr.). Whole velella float material 
and partly deacetylated velella float material, like carrageenin, 
were suspended in 0.9% saline and studied at levels identical (mg. 
for mg.) to those used previously. 
Carrageenin produced a rapid-onset, short-term inflammation in 
the injected paw which appeared at +1 hr., reached a peak at +3 hr., 
and which disappeared after +2 days. Through +1 day, this swelling 
was statistically significantly different from the saline vehicle 
control at a probability level of p (0.001. This information 
correlates well with the results obtained in the previous study 
9.5 
Table V: r·'lean injected pa"'i< volumes of rats Hith carrageenin-induced inflammation or velella-induced 
infla~~tion (phlogiston vehicle: 0.9% saline) -- confirrration study 
Change from preinjection volume, ml. (± 1 SEM) 
Preinj. 
r.r volume, rnl. +5 min. +1 hr. +3 hr. +5 hr. +1 d. +2 d. +3 d. 
0.9% Saline vehicle 10 1.20 +0.13 +0.09 +0.08 +0.11 +0.01 +0.03 +0.00 
control (0.01) ( 0. 02) (0.02) (0.02) (0.03) (0.02) (0.02) 
Carrageenin 10 1.18 +0.17 +0.51£ +0.7il +0.60£ +0.21£ b +0.13- +0.02 . 
(0.03) (0.05) (0.05) (0.07) (0.02) (0.02) (0.04) 
I·Ihole velella float 10 1.23 +0.09 +0.11 +0.45~ +0.432 +0 .27,2 +0.12~ +0.12£ 
rr.c.terial (o .o2) (0.04) (0.06) (0.04) (0.03) (0.02) (0.03) 
Partly deacetylated 9 1.12 +0.10 +0.09 +0.29£ +0.20 +0.15§: +0.13h +0.13£ 
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Table V continued. 
Change from preinjection volume, rnl. (: 1 SE!Vl) 
+4 d. +5 d. +6 d. +7 d. +8 d. +9 d. +10 d. +11 d. +12 d. 
0.9% Saline vehicle +0.01 -0.01 +0.05 +0.04 +0.03 -0.01 -0.04 o:-0.04 • +0.01 
control (0.02) (o.oL;.) (0.04) (0.03) (0.02) (0.03) (0.04) (0.02) (0.04) 
Carrageen i11. +0.04 +0.07 +0.11 +0.06 +0.07~ +0.02 +0.02 -0.02 -0.03 
(0.02) (o. 02) (0. 02) ( 0. 02) (0.03) (0. 02) (0.03) (0.03) (0.06) 
\1'hole velella float b +0.16- +0.15£ +0.22h +0.16~ +0.13§: +0.07 +0.02 +0.03 -0.01 
r..aterial (0.04) (0.03) (0.03) (O.OL.L) (0.04) (0.03) (0.03) (0.05) (0.04) 
Partly deacety1ated +0.15:9. +0.16~ +0 .219. +0 .23!?. +0.15:!2 +0.10§: +0.07§; +0.02 +0.07 
velella float material (0.03) (O.OL~) (0.02) ( 0. 02) (0.03) (0.03) (0.03) (0.03) (0.02) 
~. h, and£. indicate p < 0.05, p < 0.01, and p <. 0.001, respectively. For all other values, 
g)0.05. - - -
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Table VI: !'Tean contralateral pa>f volumes of rats Hith carrageenin-induced inflammation or velella-
incluced inflammation (phlogiston vehicle: 0. 9% saline) --- confirmation study 
Change from preinj~ction .:volume, ml. ( ± 1 SEM) 
Preinj. 
N·· .. volume, ml. +5 min. +1 hr. +3 hr. +5 hr. +1 d. +2 d. +3d. . 
0.~~ Saline vehicle 10 1.21 -0.03 -0.01 -0.01 +0.01 +0.00 +0.01 -0.01 
control (0.03) (0.02) (0.02) (0.02) (0.03) (0.04) (0.03) 
Cru.--rageenin 10 1.22 -0.02 -0.03 -0.01 -0.05 -o.o6a -0.02 -0.05 
(0.02) (0.01) (0.02) (0.03) co .02) (0.01) (0.04) 
:·:hole vel ella float 10 1.24· -0.05 -0.03 -0.05 -0.10 -0.03 -0.02 -0.05 
:material (0.01) ( 0 •. 0)) (0.01) (0.05) (0.03) (0.02) (0.04) 
Partly deacetylated. 9 1.10 -0.04 -0.01 +0.02 -0.03 -0.01 +0.01 +0.00-
velella float material (0.02) (0.04) (0.04) (0.05) (0.03) (0.04) (0.03) 
" 
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Table VI conti.'1ued. 
Change from preinjection volume, ml. (tl S3I<l) 
+4 d. +5 d. -t6 d. +7 d. +8 d. +9 d. +10 d. +11 d. +12 d. 
+0.01 -0.02 +0.09 +0.06 +0.03 +0.04 -0.02 +0.01 . +0.02 
(0.03) (0.04) (0.04) (0.03) (0.02) (0.03) (0.05) (0.02) (0.04) 
-0.05 -0.01 +0.03 -0.01 +0.03 -0.02 -0.02 -0.05 -0.04 
(0.02) (0.02) (0.02) (0.02) (0.03) (0.03) (0.03) (0.04) (0.05) 
-0.01 +0.01 +0.06 +0.06 +0.07 -0.04 +0.01 -0.05 -0.05 
(0.04·) (0.03) ( 0. 02) (0.04) (0.03) (0.03) (0.03) (0.03) (0.03) 
-0.01 +0.03 +0.10 +0.09 +0.10 +O.o6 +0.04 +0.01 +0.08 
(0.03) (0.04) (0.04) (0.03) (0.03) (0.03) (0.03) (0.03) (0.06) 
2 b . c 
-·, -, a..'1d - indicate p <. 0. 0 5, .P <. 0. 01, . and p <. 0. 001, respectively. For all other values, 
g > 0.05. -
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Fig. 15 -- A comparison of the types of inflammation induced 
in the contralc>.ten~l paHs of animals by carrageenin, 
i'ihole velella float material, and partly dcacetylated 
velella float material. 
(phlogiston vehicle: 0.9% saline) 
Values indicate change from preinjection volume, ml. 
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(see Table V vs. Table III). Whole velella float material and 
partly deacetylated velella float material also produced a.rapid-
onset, carrageenin-like inflammation and, again, this inflammation 
was not as intense, Whole velella float material produced an 
inflammation two-thirds as.intense as that produced b,y carrageenin. 
In this study, whole velella float material produced a peak swelling 
of 0.45 ml. at +J hrs (see Table V and Figure 14), whereas, in the·· 
last study, this material produced a peak swelling of 0.51 m1 {see 
Table III). Partly deacetylated velella material produced an 
inflammation which was only about one-third as great as that produced 
b,y carrageenin. In this study, deacetylated velella float material 
produced a peak swelling of o.29 ml. at +J hrs (see Table V and 
Figure 14), while in the previous study, deacetylated material 
produced a peak swelling of 0.)6 ml. (see Table III). The velella 
materials, in both studies, produced a type of inflammation which 
persisted much longer than the inflammation produced by carrageenin 
(see Tables III and V, . and Figures 7-10 and 14). On an equal 
weight basis, whole velella float material appeared to possess more 
phlogistic ability than the deacetylated velella material {see 
Table V and Figure 14). This information is consistent with the 
information gathered in the previous study, ''Like carrageenin, there 
was absolutely no evidence of swelling or of secondary lesions in the ( ·: .. 
contralateral paws of animals receiving injections of vella materials 
(see Table Vi and Figure 15). 
The results shown in Tables VII and VIII, and in Figures 16-19 
are from a study performed in order not only to reproduce the data 
we had already gathered about the phlogistic capacities of whole 
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Table VII: Mean injected paN volumes of rats Hith pedal edema induced by carrageenin or cotton as 
contrasted with pedal edema induced by certain chitinous materials (phlogiston vehicle: 0.9% saline) 
Change from preinjection volume, ml. ( 1 SEM) 
r,r 
Preinj. 
volume,. ml. +5 min. +1 hr. +3 hr. +5 hr. +1 d, +3 d. +6 d. 
0.9% saline vehicle '9 1.28 +0.19 +0.10 +0.14 +0.11 +0.02 -0.03 -0.10 
control (0.03) (O.OJ) (0.02) (0.03) ( 0. OJ) . ( 0. 02) (0.04) 
Carrageenin 10 1.26 +0.12 +0.46.£ +0.94~ +0.89£ +0.24£. +0.05~ -0.05 
(0.03) (0.05) (0.06) (0.08) (O.OJ) (0.03) (0.03) 
Cotton 10 1.24 +0.16 +0.10 +0.20 +0.18 +0.11§!: +0.07 +0.01~ 
(0.03) ( 0. 02) (0.04) (0.03) (O.OJ) (0.05) (0.03) 
\·!hole velella float 10 1.21 +0.14 +0.14 +0.40~ +0.4o<l +0.20£ +0.11]2 +0.04~ 
material (0.02) (O.OJ) (0.05) (O.OJ) (o.o2) (0.04) (O.OJ) 
Fartly deacetylated . 10 1.25 +0.15 +0.18 +0.33]2 +0.22 +0.13 a +0.08- +0.02 
velella float material (0.04) (O.OJ) (0.05) (0.05) (0.05) (0.04) (0.05) 
?a:rtly d.eacetylated 10 1.24 +0.07~ +0.05 +O.J4Q +O.J2Q. +0.08 +0.06~ -0.04 
shrimp material (O.OJ) (0.04) (0.05) (0.04) (0.05) (O.OJ) (0.04) 
Fartly deacetylated 10 1.23 +0.19 +0.09 +0.4Jh +0.58£ +O.JO<l +0.28£ +0.21£ 
loligo pen material (0.04) (O.OJ) (0.07) (0.07) (0.04) (0.06) (0 ."06) 
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Table VII continued. 
Change from preinjection volume, ml. ( 1 SEH) 
+9 d. +12 d. +15 d. +18 d. +21 d. 
0.~ saline vehicle -0.04 -0.05 -0.03 -0.01 -0.04 
control (0.03) (0.03) (0.03) (0,0L~-) (0.02) 
Carrageenin +0.01 -0.03 -0.01 -0.07 -0.02 
(0.03) (0.03) (0.02) (0.03) (0.02) 
Cotton +0 .OlJ.~ +0.08~ -0.01 +0.01 -0.02 
(0.02) ( 0. 02) (0.04·) ( 0. 02) (0.03) 
~·:hole velella float +0.07 +0.03 +0.111? +0.09~ +0.05 
material (O.OL~) (0.03) (0.04) (0.03) (0.05) 
I'artly deacetylated +0.01 +O.o6e +0.02 +0.03 -0.01 
velella float ~aterial (0.04) (0.03) (0.04) (0.04) (0.04) 
• 
Partly deacetylated -0.04 -0.01 -0.02 -0.02 -0.02 
shrinp rraterial (0.03) (0.02) (0.04) ( 0. 02) (0.03) 
Partly deacetylated c +.029£ +0.23£ +0.25h '+0.24£ +0.23-
loligo pen material (0.05) (0.05) (0.04) (0.06) (0.07) 
~. E, and£ indicate p < 0.05, p < 0.01, and p < 0.001, respectively. For all other values, 
p > 0.05. - -
dt 
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Table VIII: l'Iean contralateral paH volumes of rat.s :-lith pedal ed.ema induced by carrageenin or cotton __ 
as contrasted rlith pedal edema induced by certain chitinous rnaterials (phlogiston vehicle: 0.9% saline) 
· Change from preinjection ~olume, ml.. ( t 1SEfti) 
N 
Preinj. 
volume, ml. +5 min • + 1 hr. + 3 hr. +5 hr. + 1 d. +3d. -+6 d. 
0.9(- saline vehicle .9 1.32 -0.02 -0.07 -0.07 -0.02 -0.0.5 -0.06 -0.12 
.control (o.oL~) (0.03) (0.03) (0.0.5) (0.03) (0.03) (o.o6) 
Carrageenin 10 1.28 -0.01 -0.04 +0.03 -0.02 -0.06 -0.07 -0.07 
(0. 02) . (0.03) (0.06} (0.03) (o. 02) (0.03) (0.04) 
Cotton 10 1.2L~ -0.04 +0.03~ +0.03~ -0.04 -0.0.5 -0.01 -0.08 
(O.OJ) (0.02) (0.02) (0.02) (0.02) (0.02) (0.03) 
1·fuole velella float 10 1.24 +0.00 -0.02 +0.02~ -0.01 -0.03 -0.02 -0.04 
material (0.03) (0.03) (0. 02) (0.02) (0.03) (0.03) (0.04) 
Partly deacetylated 10 1.26 +0.02 -0.01 +0.02~ -0.0.5 -0.04 -0.04 -0.08 
velella float material (0,03) ( 0. 02) (0.03) (0.02) (0.02) (0.02) (0.03) 
Partly deacetylated 10 1.24 +0.01 -0.07 -0.02 -0.04 -0.12 -0.01 -0.08 
shrimp m?.terial (0.02) (0.03) (0.03) (0.03) (0.03) (0.04) (0.0.5) 
Partly deacetylated 10 1.21 +0.0.5 -0.01 +0.06£ +0.04 -0.03 +0.07 +0.02 
loligo pen ~~terial (0.03) (0.03) (0.02) (0.03) (0.03) (0.0.5) ( 0 ·~.0.5) 
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Table VIII continued. 
Cha..Ylge from preinjection volu;rre, ml. ( 1 SEtfJ) 
+9 d. +12 d. +15 d. +18 d. +21 d. 
0.9% saline vehicle -0.08 -0.06 -0.07 -0.09 -0.08 
control (0.03) (0.04) (0.03) (0.05) (0.03) 
Ca.....-rrageenin -0.07 -0.08 -0.09 -0.10 -0.09 
(0.03) (0.03) (0.03) (O.OJ) (0.03) 
Cotton -0.03. -0.02 -0.05 -0.06 -0.07 
(o. 02) (0.02) (0.02) (0.01) (0,03) 
tThole velella float -0.06 -0.02 -0.04 -0.08 -0.08 
mate:c.-ial (o. ol~) (o. 02) (0.02) (0.03) (0.02) 
Partly deacetylated -0.06 -0.03 -0.06 -0.05 ' -0.09 
velella float material (0.03) (0.05) (0.03) (o .o2) (0.02) 
Fartly deacetylated -0.07 -0.07 -0.09 -0.07 -0.13 
shrimp material (o. 02) (0.01) (o. 02) (0.03) (0.03) 
Fartly deacetylated +0.03~ 
b a +O.o2e , +o.oo~ +0.08- +0.04-
loligo pen material (0.02) (0.02) (0.03) (0.02) (0.02) 
~. h, and. ~ indicate 12 <. 0.05, p < 0.01, and p < 0~.001, respectively. 
p > 0.05. - -
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For all other values, 
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Fig. 16 - A compc:.rison of the types of inflammation induced 
in the i:niected paKs of animals by carrageenin, 
Hhole velella, partly deacetylated velella, and 
cotton. 
(phlogiston vehicle: 0.9% saline) 
Values indicate change from preinjection volume, ml. 
8 carrageenin 
II Nhole ·velella 
.IJ deacetylatecl veJ.ella 
() cotton 
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Fig. 17 ··- A comparison of the types of inflammation induced 
in the injected paHS Of animals by cteacetylated loligo, 
deacetylated shrimp, deacetylated velella, &~d cotton. 
(phlogiston vehicle: 0. 9;~ saline) 
Values indicate change from preinjection volume, ml. 
I 
b deacetylated loligo 
(> deacetylated shrimp 
I] deacetylated velella 
<a cotton 
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Fig. 18 -- A comparison of the types of inflarnn.ation induced 
in the contralateral pa1·rs of aniraals by ca.rrageenin 1 
Hhole velella 1 partly deacetylated velella 1 and 
cotton. 
(phlogiston vehicle: 0. 9;'j saline) 
Values indicate cha.11ge from pre injection volume 1 rnl. 
CD carrageenin 
, 11 1~hole velella 
10 deacetylated velella 
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0 0. 97; saline 
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Fig. 19 A comparison of the types of inflamrna.tion induced. 
in the cont:calateral paHs of animals by deacetylated 
loligo, deacetylated shrimp, c1eacetylated velella, 
. and cotton. 
(phlogiston vehicle: 0.9% saline) 
Values indicate change from preinjection volurr.e, ml. 
~ deacetylated loligo 
~ cleacetylated shrimp 
I] deacetylated vel ella 
() cotton 
0 0.~; saline 
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more importantly, to demonstrate the. phlogistic relationship of 
these materials to other chitinous materials. All materials were 
suspended in 0.9% saline and appropriate controls were utilized. 
The phlogistic capacity of cotton was also analyzed in this 
study. 
As expected, carrageenin produced a rapid-onset, short-term 
inflammation in the injected paw which appeared at +1 hr., reached.· 
a peak of 0.94 ml. at +3 hrs., and which then disappeared after +3 
days. The probability level of significance for carrageenin inflam-
mation was p(O.OOl up through +1 day (See Table VII). Whole 
velella float material and partly deacetylated velella float material 
also produced a rapid-onset type inflammation appearing and becoming 
statistically significa~t at +3 hrs., but this inflammation was not 
as intense as that produced by carrageenin. Whole velella float 
material produced a peak in swelling of +0.40 ml. at +3- 5 hrs. and 
the probability level of significance was !(0.001. This amount 
of swelling was only about one-third as intense as that produced 
by carrageenin. All this information is consistent with the in-
formation reported in the two previous studies. Partly deacetylated 
shrimp material and partly deacetylated loligo pen material also 
produced a rapid-onset type of inflammation, reaching peak effect 
at +3 hr. and +5 hr. respectively. Partly deacetylated shrimp 
material, like partly deacetylated velella float material, seemed 
to produce an inflammation which was about one-third as intense as 
that produced by carrageenin. Partly deacetylated loligo pen 
rna terial , on the a>ther hand, seemed to produce an inflammation which 
was about two-thirds as intense as that pr,oduced by carrageenin. 
The inflammation produced by deacetylated shrimp had disappeared by 
86 
+3 days; however, the inflammation produced by deacetylated 
loligo persisted throughout the observation period (see Table 
VII and Figure 17). When all the deacetylated forms 
in this study are compared together for their phlogistic capacities, 
it appears that deacetylat~d loligo pen material possessed the most 
phlogistic action (peak swelling of 0.58 ml;); partly deacetylated 
shrimp material held the second position (peak swelling of +0.)4 mL); 
and partly deacetylated velella float materials showed the least 
phlogistic capacity (peak swelling of +0.33 ml.) (see Table VII 
and Figure 17). There was no evidence of swelling or of secondary 
lesions in the contralateral paws of animals receiving injections of 
any of the materials analyzed in this study (see Table VIII and 
Figures 18-19). 
The results shown in Tables IX and X and in Figures 20-27 are 
from a study performed in order to determine the phlogistic capacities 
of the whole and deproteinated forms of loligo pen material and 
shrimp material. All materials were suspended in 0.9% saline and 
appropriate saline and carrageenin controls were run concurrently. 
The phlogistic capacity of cotton was also analyzed. 
As in all previous studies, carrageenin produced a quick-onset, 
short-duration type of inflammation, producing a peak of swelling of 
+0.86 ml. at +3 hrs and disappearing after +2 days. Probability level 
of significance was 1: (0.001 through +5 hrs. (see Table IX). vlhole 
loligo and deproteinated loligo pen material also produced a quick-
onset type of inflammation, but this inflammation was not as intense as 
that produced by carrageenin. Whole loligo pen material produced a 
peak of swelling of +0 .42 ml. at +3 hrs. (about 44% of the st-relling 
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Table ·rx: Mean injected paw volumes ~f rats with pedal edema L~duced by carrageenin or cotton as 
contrasted with pedal edema induced_by certain chitli1ous materials (phlogiston vehicle: 0.9% saline) 
" Change from pre injection volume 9 ml. ( ± 1SEM) 
Preinj. 
N volume_, ml. +5 lT!in. +1 hr. +3 hr. +5 hr. +1 d. +2 d. +3 d. 
0.9% saline vehicle 10 1.18 +0.16 +0.16 +0.15 +0.09 +0.08 +0.07 +0.12 
control (0.02) (0.03) (0.03) (0.03) (0.02) (0.02) (0.03) 
+0.23 +0.63£ +0.86.£ 
c b b 
Carrageenin 10 1.17 +0.86- +0.26- +0.19- +0.20 
(o.o6) (0.08) (0.11) (0.09) (0.05) (0.03) (0.04) 
Cotton 10 1.17 +0.17 +0.20 +0.26 
b +0.28- +0 .20£. +0.13 +0.18 
(0.03) (0.05) (0.06) (0.06) (o. 02) (0.03) (0.01) 
\'Thole 1o1igo pen 10 1.21 +0.20 +0.21 +0.42£ +0.38£: +0.3~ +0.25£: +0.292 
material (0.02) (0.05) (0.03) (0.05) (0.06) (0.03) (0.03) 
Dep:roteinated loligo 10 1.19 +0.18 +0.15 +0.19 +0.40£ +0.2812 +0 .199. +0 .20 
pen material ( o. Olr) (o .o1_,_) (0.03) (o. o6) (0.04) (0.04) (0.05) 
\<Thole shrimp 10 1.21 +0.22 +0.31 h +O.Li-8£ +0.51£ +0 .292 +0 .20£ +0 .2612 
material (0.03) (O.OL~) (0.05) (0.04) (0,06) (0.03) (0.02) 
+0.23~ +0.30s +0.42Q +0.40£ 
, . b 
DeproteL~ated shrimp 10 1.17 
D +0.24- +0.17- +0.19 
material (0.02) (O.OLJ.) (0.05) (0.04) (0.01-:-) (0.03) (0.03) 
l'lllllllllfT' Fi''lln:~' 1 1 ·i·; ! UffHJ:.xn~I:::J[i··!PIUl: "J::··JT'mJ1f1''"1Tfll'l'" .... nl..,..riii!T"'WIII'1-n-'fn"n"l1"n•o•..-,.•-.-'- ,,. c-···-- .,, .•.. ,. ~~·.,--·~·- .. 
,1111111' ,,1 I, 
Table IX continued. 
Change from preinjection volume, ml. (±1 SEM) 
+4 d. +5 d. +?d. +9 d. +11 d. 
0.9,1, saline vehicle +0.15 +0.20 +0.24 +0.30 +0.29 
control (0.01) . (0.01) (O.OJ) (0.03) (0.03) 
Carrageenin +0.20 +0.22 +0.30 +0.29 +0.32 
(0.03) (0.04) (0.04) (0.04) (0.04) 
Cotton +0.18 +0.18 +0.23 +0.28 +0.28 
(0 .. 01) ·. (0.03) (o. 02) (0.04) (0.05) 
. 4a +O.J4 \·:hole loligo -tO .2 - +0.25 +0.29 +0.30 
pen material (0.04) (0.02) (0.03) ( 0. 02) (0.03) 
~eproteinated loligo +0.17 +0.27§.: +O.Jl+ +0.31 +0.30 
pen In2.terial (0.07) (0.03) (0.04) (0.04) (0.05) 
q 
+0.302 b \-!hole shrimp +0.38- +0.35~ +0.34 +0.33 
material (0.04) (0.05) (0.04) (0.05) (0.05) 
DeproteL~ated shrimp +0.18 +0.19 +0.24 +0.25 +0.26 
material (0.01) (0.03) (0. 02) (0.02) (0.04) 
~. £, and £indicate p ~ 0.05, p < 0.01, and p < 0.001, respectively. For all other values, 
E. ) 0. 05. \ - -
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Table X: !Jiea.n ·contralateral pa>-: volumes of rats -,.;i th p6dal edema induced by carrageenin or cotton 
as contrasted with pedal edema induced by certain chitinous rr.3:-terials (phlogiston vehicle: 0.9% saline) 
Change from preinjection volume, ml. (±1 SEM) 
Preinj. . 
N volume, ml. +5 min. +1 hr. +3 hr. +5 hr. +1 d. +2 d. +.3 d. 
0.9,1. saline vehicle 10 1.18 -0.02 +0.00 -0.01 +0.01 +0.00 +0.04 +0.13 
control (0.02) (0.02) (0.01) (o .02) (0.0.3) (0.0.3) (0.0.3) 
Carrageenin 10 1.19 +0.01 +0.00 +0.01 +0.01 +0.01 +0.06 +0.12 
(0.0.3) (0.03) (0.03) (0.0.3) (0.04) (0.0.3) (0.04) 
Cotton 10 1.18 +0.04 +0.00 +0.01 +0.02 +0.02' +0.05 +0.06 
(0~03) (0.0.3) (0.02) (0.03) (0.04) (0.0.3) (0.0.3) 
H10le loligo pen 10 1.20 +0.02 +0.00 +0.01 +0.03 +0.02 +0.05 +0.11 
material ( 0 .02) (0.02) (0.03) (0.02) (0.01) (0.02) (0.03) 
Deproteinated lo1igo 
pen material 10 1.17 -0.03 -0.05 -0.01 +0.0.3 -0.02 +0.00 +0.12 
(0.04) (o.o4) (0.04) (0.04) (0.04) (0.03) (o.o4) 
~~hole shrimp 10 1.24 +0.05 +0.01 +0.04 +0.08 +0.00 +0.03 +0.13 
rnaterial (0.03) (0.03) (0.03) (0.04) (O.OJ) (0.02) (O.OJ) 
Deproteinated shrimp 10 1.20 +0.02 +0.01 +0 .. 05 +0.05 +0.00 +0.06 +0.08 
material (0.02) (0.02) (0.02) (0.0.3) (0.03) (0.03) (0.02) 
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Table X continued. 
Change from pre injection volume, ml, (± 1 SEM) 
-1-4 d. +5 d. +7 d. +9.d. +11 d. 
0.9% salL~e vehicle +0.10 +0.20 +0.24 +0.23 +0.30 
control (0.92) (0 .02) (O.OJ) (0.05) (0.03) 
Car.::-ageenin +0.13 +0.20 +0.22 +0.30 +0.30 
(0.03) (0.04) (0.02) (0.04) (0.03) 
Cotton +0.13 +0.16 +0.21 +0.27 +0.27 
(0.02) (0.03) (0.02) (0.02) (0.03) 
lofhole loligo pen +0.14 +0.17 +0.28 +0.28 +0.29 
mateTial (0.03) (0.04) (0.03) (0.04) (0.04) 
Deproteinated loligo +0.10 +0.14 +0.18 +0.22 +0.25 
pen rna terial (0.03) (0.05) (0.03) (0.04) (0.03) 
Hhole shrimp +0.13 +0.22 +0.24 +0.20 +0.29 
material (0.02) (0.03 (0.03) (0.04) (0.0!-J-) 
Deproteinated shrimp +0.13 +0.16 +0.29 +0.23 +0.26 
(0.02) (o. 02) (0.03) (0.02) (0.04) 
~, E, and S indicate p < 0.05, p < 0.01, and p < 0.001, respectively. For all other values, o 
p > o.os. - - 7 
~ 
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Fig. 20 ·-- A comparison of the types of inflammation induced. 
in the injected pav1s of aYJ.imals by carrae;eenin, \·:hole 
loligo pen material, deproteinated loligo pen material, 
and cotton. 
(phlogiston vehicle: 0.~ saline) 
Values indicate cha.nge from prc:injection volume, ml. 
~-
• ca:croceenin 
A Hhole loligo 
A deproteinated loligo 
() cotton 
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Fig. 21 -- A comparison of the types of influrru:tation induced 
in the in iecterl pa;·is of 2nimals by carra.geenin, ,,:hole 
shrimp material, deproteinated shrimp material, and 
cotton. 
(phlogiston vehicle: 0.9% saline) 
Values indicate change from preinjection volume, ml. 
• carrageenin • Hhole shrimp 
<) deproteina.ted shrimp 
<t cotton 
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Fig. 22 ---- A comparison of the types of inflamr:J.::"Ltion induced 
in the injected paws of animals by \·:hole shrimp 
material, deproteinated shrimp material, Hhole 
loligo pen material, and deproteinated loligo 
pen material. 
(phlogiston vehicle: 0.9% saline) 
Values indicate change from preinjection volume, r.U. 
+ '-Jhole shrimp 
~ deproteinated shrimp 
A Hhole lolit?;o 
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Fig. 23 -- A comparison of the types of inflammation induced 
in the injected. paHs of animals by ca.rrageenin, v-rhole 
loligo pen material, v:hole shrimp material, and cotton. 
(phlogiston vehicle: 0.~ saline) 
Values indicate change from preinjection volume, ml. 
~ 
• carrageenin ~ e----fi ~ 
A ·,rhole loligo 
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Fig. 2L~ -- A comparison of the types of inflammation induced 
in the injecterl pa.Hs of animals by deproteinated 
loligo pen material, deproteinated shrimp material, 
and cotton. 
(phlogiston vehicle: 0. sr;:; saline) 
Values indicate change from preinjection volume, ml. 
A d.eproteinated loligo 
~ deproteinated shrimp 
<» cotton 
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Fig. 25 -- A compar":i.son of the types of inflamrna,tion induced 
rrhole loligo pen material, deproteinated loligo pen 
material, and cotton. 
(phlogiston vehicle: 0.9% saline) 
Values indica.te change from preinjee--t-iel'l.-velume-, ml • 
• carrageenin 
A i;hole loligo 
4 deproteinated loligo 
<» cotton 
















































Fig. 2fl -- A comparison of the types of inflammation induced 
inl::he conuaTateral paHs of animals by carrageenin, 
1-:hole shrimp material, deproteinated shrimp material, 
and cotton. 
(phlogiston vehicle: 0.9% saline) 
Values indicate change from preinjection volume, rru • 
• carrageenin • 'tihole shrimp 
~ deproteinated shrimp 
() cotton 
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Fig. 27 -- A comparison of the t;ypes of inflammation induced 
in the con trc:.laterG1 pa·.1s of animals by >·ihole shriml' 
material, deproteinated shrimp material, >;hole 
loligo pen material, and deproteinated loligo 
pen rr.aterial. 
(phlogiston vehicle: 0.9% saline) 
Va.lues indicate change fron preinjection volume, ml • 
• Hhole shrimp 
~ deproteinated shrimp 
A Hhole loligo 
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ficance at the above mentioned peak times was g_<O.OOL The in-
flammation produced by the two above forms of loligo pen material 
persisted longer than that produced by carrageenin, ~·~· whole 
loligo pen material inflammation persisted through +4 days, while 
deproteinated material inflammation persisted through +5 days 
(see Table IX and Figure 20). Whole shrimp·and deproteinated 
shrimp material produced a peak of swelling of +0.51 ml. at +5 hrs~ 
108 
!-----tabcut-60%-cf-the-swel-l:ing-produced-by-carr~geenin-at-tne-sa:me--------------
time), and deproteinated shrimp material produced a peak of swelling 
of +0.42 ml. at +J hrs. (about 46% of the swelling produced by 
carrageenin at the same time). Probability levels of significance 
for the two rna terials at the peak times was g ( 0. 001. While 
the two forrr~ of loligo materials produced an inflamrration which 
persisted longer than the inflammation produced by carrageenin, 
whole shrimp material produced a type of inflammation which was 
detectable through +9 days. Deproteinated shrimp material produced 
an inflammation which lasted through +2 days (see Table IX, Figure 21). 
Whole cotton produced only a sligh degree of inflammation which 
was significantly different from the saline vehicle control at 
+5 hrs. and at +1 day (see Table IX). When the whole forms in this 
study are compared to one another for their phlogistic capacity, 
it appears that whole shrimp had more phlogistic capacity than does 
whole loligo pen inaterial (see Table IX and Figure 23). \vhen the 
deproteinated forms in this study are compared to one another for 
their phlogistic capacity, it appears that deproteinated shrimp had 
more phlogistic ability than does deproteinated loligo pen material 
(see •rable IX and Figure 24). There was no evidence of swelling or 
of secondary lesions in the contralateral paws of the animals used 
in this study (see Table X and Figures 25-27). 
Short-term, si.ngle-dose drug studiesa 
The results summarized in Tables XI-XIV and in Figures 28-31 
are from a one-level drug study which was performed in order to de-
termine possible mechanisms of action whereby chitinous materials 
induce inflammation. Whole velella float material was chosen as 
the type of chitinous material to be studied because of its ready 
availability. Theoretically, the information gathered concerning 
whole velella-induced inflammation should be representative of 
most whole-forms of chitinous materials. 
Velella-induced pedal edema was reduced by premedication with 
phenylbutazone at· +3 hrs. and at +5 hrs. by 31% and 33%, respectively 
(see Table XI and Figure 28). Indomethacin and chlorpromazine were 
also effective in reducing velella-induced inflammation at +3 hrs. 
and at +5 hrs. by 26% and 33%, reapectively. Chlorpromazine reduced 
velella-induced inflammation at +3 hrs. and +5 hrs. by 36% and 40%, 
respectively (see Table XI and Figure 28). Since the previous work 
has shown that there is no statistically significant degree of swelling 
in the contralateral paw, the effectiveness of these drugs upon 
contralateral paw volume was expected not to be significant (see 
Table XII and Figure 29). Table XIII and XIV and Figure 30 and 
31 show carrageenin data run concurrently. Phenylbutazone was 
effective in reducing carrageenin-induced pedal edema at +3 hrs. by 
16% (see Table XIII and Figure JO). Indomethacin and chlorpromazine 
were somewhat more .effective in retarding carrageenln-induced 




Drug treatment dosage, 
at -1 hr. mg./kg. lJ 
Agar vehicle ---- 20 
Phenylbutazone 100 20 
Indomethacin 10 20 
Chlorpromazine 100 20 
- I 
Change from preinjection rlume. 
Preinj. 
,_volume, ¢].. +5 ·min. 
1.17 +0.17 
(0.03) 
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(0 .. 04) 
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I 
Significa."'l.tly different from the corresponding "agar vehicle" value: 
~p < 0.05; ~p < 0.01; ·~p < 0.001. For all other values, p) 0.05. - -
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Table XII: Effects of :phenylbutazone, indomethacin, and chlor:prornazin.e on mean contralateral 
pa11 volumes of :rats Hi th velella-induced inflarnm.a tion (phlogiston vehllcle: 0. 9% saline) 
I 
Oral 
Change tro.n preinjection tolume, ml.. {! 1 SEM) 
Drug treatrr.ent dosage, Preinj. · . 1 
at -1 hr. mg./k .. g. N volume, ml. +5 mm. +1 hr. +3 hr. +5 hr. 
I 
Agar vehicle 20 1.14 
Phenylbutazone 100 20 1.10 
Indomethacin 10 20 1.11 































Significantly different from the corresponding "agar vehicle" value: 
a b c -E. < 0.05; ~ < 0.01; -g < 0.001. For all other values, g) 0.0.5. 
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Table XIII: Effects of phenylbutazone, indomethacin, and chlorpromaz~.ne on mean injected 
pa~ volumes of rats with carrageenin-induced infla~~ation (phlogistonlvehicle: 0.9% saline) 
. . I 
Change from preinjection volume P ml. ( ± 1SEM) 
I 
Drug treatment 






Agar vehicle 20 1.15 
.Phenylbutazone 100 20 1.21 
Indomethacin 10 20 1.17 
Chlorpromazine 100 20 1.14 
+.5 min. 
+0.17 
( 0. 02) 
+0.18 
















Significantly different from the corresponding "agar vehicle" value: 
a < b c ) -p 0.05; -p < 0,01; -p < 0.001. For all other values p 0.05. 
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Table XIV: Effects of phenylbutazone, indomethacin, and chlorpromazi:rJ.e on mean contralateral 
paw volumes of rats -...rith carrageenin-induced inflammation (phlogiston !vehicle: 0.% saline) 
Change f'rom pre injection j1olume, ml. ( ± 1SEM) 
Oral 
Drug treatment dosage, Preinj; 
I 
at -1 hr. mg; ./kg, N volume, ml~ +5 min. +1 hr. +3 ~r. 
T 
Agar vehicle ---- 20 1.12 +0.00 +0.00 -0. u)2 
. ( 0. 01) (0.02) ( 0. ~)2) 
1.16 
I 
Phenylbutazone 100 20 +0.00 +0.00 +0. u)2 
(0,02) (0. 02) ( 0. ~)2) 
. I 
Indomethacin 10 20 1.14· -0.03 -0.04 -0. ~)6 
(0.02) (0.01) ( 0. ~)2) 
I 
Chlorpromazine 100 20 1.10 -0.02 +0.03 -0.~)1 
(0.02) (0.02) ( I ' o.r! 
I 
Significantly differe~t from the corresponding "agar vehicle" value: 
~p < 0.05; l>p <. 0.01; 2p <. 0.001. For a.ll other values, p ') 0.05. - - -













Fig. 28 - Effects of phenylbutazone, indomethacin, and chlor-
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Fig. 29 - Effects of phenylbutazone, indomethacin, and chlor-
promazine on mean contralateral pa·.1 volumes of rats 
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Fig. 30 - I~ffects of phenylbutazone, indomethacin, and chlor-
























































































Fif~. 31 - "8ffects of phenylbutazone, indomethacin, and chlor-
promazine on mean contra.lateral Ilo)l volumes of rats 
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zine reduce carrageenin-induced inflammation at +3 hrs. by 29% and 
at +5 hrs. by 20% (see Table XIII and Figure 30). As with whole 
velella-induced inflammation, there was no statistically significant 
drug effect in the contralateral paws (see Table XIV and Figure 31). 
The results summarize<; in Tables XV-XVIII and in Figures 32-35, 
are from another study which was performed in order to further de-
lineate possible mechanisms of action whereby chitinous materials · 
to be examined as an example of chitirious material. The only 
difference between this study and the previous one was the type 
of drugs studied: aspirin, hydrocortisone, and cryogenine. 
Velella-induced inflammation was significantly reduced with 
aspirin at +1 hr. by 5Q%, at +3 hrs. by 49%, and at +5 hrs. b,y 23,%. 
Velella induced inflammation was also significantly reduced with 
hydrocortisone at +3 hrs. by )4%. Velella-induced inflammation 
was not significantly reduced with cryogenine (see Table XV and 
Figure 32). There was no statistically significant amount of 
swelling in the contralateral paws, so no measure of drug effective-
ness could be obtained or expected (see Table XVI and Figure 33). 
Table XVII and XVIII and Figure )4 and 35 show carrageenin data run 
concurrently. Carrageenin-induced inflammation was significantly 
reduced with aspirin at +1 hr. by 44%, and at +3 hrs. by 41%, 
and at +5 hrs. by 27%. Carrageenin-induced inflammation was also 
significantly reduced with hydrocortisone at +3 hrs. by 30%, and 
with cryogenine at +3 hrs. by 28% (see Table XVII and Figure )4). As 
with the whole velella material, there was no statistically significant 
amount of swelling induced by carrageenin in the contralateral paw 




Table XV: Effects of aspirin, hydrocortisone, and cryogenine on mean I L11jected 
paw volumes of rats >lith velella-induced inflammation (phlogiston veh:
1
Lcle: 0. 95's salL"le) 
Drug treatment 
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Significantly different from the corresponding "agar vehicle" value: 
a b c -g <. 0.05; -p < 0.01; -p <. 0.001. For all other values, p ') 0.05. 
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Table XVI: Effects of aspirin, hydrocortisone, and cryogenine on me, contralateral 
paw volumes of rats Hith velella-induced inflammation (phlogiston veh~cle: 0.9% saline) 
I 
Ore>.l 
Change from preinj~c_tion Jrlume, m1. (:t 1 SEM) 
Drug treatment 


















































Significantly different from the corresponding "agar vehicle" value: 
a b c ) -p ( 0.05; -p ( 0.01; -p < 0,001. For all other values p 0.05. 















Table XVII: Effects of aspirin, hydrocortisone, and cryogenine on meah injected pa1-1 
volumes of rats >ri th carrageenin -induced inflammation (phlogiston vehi~le: 0. 9:~ saline) 
Drug treatment 
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Significantly different from the corresponding "agar vehicle" value: 
a <. b c -p 0.05; -R < 0.01; -p <. 0.001. For all other values, p) 0.05. 
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Table :x.·vrrr: Effects of aspirin, hydrocortisone, and cryogenine on me!m contralateral 
pau volu"" s of rats "i th carrageen in-induced inflammation (phlogiston: I 0 . % saJ.in e ) 
Drug treatment 



















Change from pre1nject1on volume, ml. (± l SEM) 











































Significantly different from the corresponding "agar vehicle'' value: 
a b · c 
-p < 0.05; -p < 0.01; -p <. 0.001. For all other values, p > 0.05. -
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Fig. 32 - Effects of aspirin, hydroco:rtisone, and cryogenine 
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Fig. 33 - Effects of aspirin, hydrocortisone, and cryogenine 
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Fig. Y-~ - Effects of aspirin, hydrocm~tisone, and cryogenine 



































































































Fig. 35 - Effects of aspirin, hydrocortisone, and cr;;ogenine 
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The la.ck of suitable experimental models in animals for 
inflammatory diseases ha.s hindered the pharmacological search for 
truly effective drugs for the treatment of those diseases in man. 
Pharmacologists conti.nue to use inadequate models to select usually 
inadequate drugs. V/ith this in mind, the present research rras 
directed ·towards deterrr1tning: 
· (i) Hhether or not invertebrate chitinous material Hottld 
be eapable of inducing an lnflammato~cy response and if so, ~= 
(ii) l·ihat the "possible mechanism(s) of action in this bduction 
process might be. 
To accomplish the objectives outlined above, several series 
of experiments nere conducted. The first series of exper:tments 
were performed i.n order to determine whether or not chitinous 
materials Here indeed capable of i.nducing an :l.nflammato:cy response, 
and if so, whether this response was similar to that ind.uced by 
ca.rrageenin (acute response) or by my co bacterium adjuvant (acute i 
and sustained response). Although the only chitlnous forms studied · 
ln these inlt:lal series of experiments were those which Here derived 
from Y£l~1.J~ lata, the lnform.-1.tion collected can be extrapolated to 
all invertebrate chitinous materials since it is only the protein 
13.5 
of the N-acetylglucosamine-protein complex which differs from one 
species of invertebrate to another). Velella lata was chosen to 
serve as the prototype chitin material in this initial series 
of experiments because it was supplied to us first and in greater 
abundance than any of the other invertebrate chitins. The results 
of the experiments which were aimed toward determining the degree . 
:----------~o~f~. similarity between chitin-induced inflammation and mycobacterium 
adjuvant-induced inflammation are depicted in Tables I and II and 
in Figures 1 - 6. The results of the experiments aimed towa.J:d 
depicting the degree of similarity between chitin-induced inflammation 
and carrageenin-induced inflammation are depicted in Tables III and 
IV and in Figures 7 - 1:3. 
The polyarthritic condition induced in the rat'qy the intra-
dermal injection of mycobacterium adjuvant into either the hind 
paw or tail is probably the most widely used "model" for rheumatoid 
disease in screening programs for anti-inflammatory drugs (17). This 
arthritic condition has been suggested variously to be due to: (~) a 
delayed hypersensitivity response to mycobacterial antigen (Jla) and/or 
(ii) an autoimmune disease whereby the responsible agent alters 
collagen (32). Some symptoms of the polyarthritis induced by 
e 
mycobacterium adjuvant in the rat are as follows: swelling and 
erythema of the injected as well as the contralateral paw, loss of 
.-··· 
the use of the ankle joints in these paws, development of secondary 
lesions in the tail, ears, and nose, and an early and abrupt decrease 
in body weight (JJ). The time course is biphasic in nature (:34). 
The first phase is represented by an immediate swelling of the 
;J __ 
injected hind paw which peaks in four days &ld clearly recedes 
between the seventh &Id eighth days, Clinical features of th~ 
phase include erythema, edema, ulceration, &Id a purulent discharge 
at the site of the inoculation. The second pahse is delayed, begin-
ning around the tenth post~inoculation day and continuing through 
the thirtieth day, This second phase can be roughly divided into 
early (11th - 16th day) and late (18th - 30th day) stages based 
on histological changes, While the first phase involves the inocu-
lated area only, the second phase involves all four paws (swelling 
of the contralateral and fore-paws is usually seen around the 
twentieth day post-innoculation) and includes various mucocut&Ieous 
lesions of the tail, eyes, ears, genitals, and skin. There is 
also an intense connective tissue reaction (fibro-/and osteoplasia) 
which produces a severe and disabling ankylotic condition. There is 
a general decrease in whole body weight during the course of the 
second phase, This description indicates that while the second 
phase includes an acute inflammatory component, the whole overall 
picture suggests a chronic inflammatory state. 
When whole, deproteinated, and deacetylated forms of Velella 
lata were suspended in mineral oil and injected in the same manner 
as was the mycobacterium.adjuvant, some swelling was noted in.the 
injected paws which was statistically significant from the vehicle 
control, but the time sequence for the swelling did not appear to 
follow any consistent pattern. Futpermore, the swelling was only 
about one-sixth of that produced by the mycobacterium. In addition, 
there was no evidence of any systemic disease in animals injected 
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with velella materials as compared to those animals receiving the 
mycobacterium adjuvant (~·§· there was no contralateral paw 
swelling or the development of mucocutaneous lesions). Therefore, 
one can conclude that invertebrate chitinous materials lack adjuvant-
like phlogistic potential. • 
Carrageenin is a mixture of polysaccharides composed of 
sulfated galactose units and derived from Irish sea moss (Chrondrus 
crispus). Its use as an edemogen was introduced by Winter~ al., (J5) 
who documented the acute localized inflammatory edema produced when 
the substance was injected into the hind paws of rats. The actual 
development of pedal edema has been described as a biphasic event ()6). 
The initial phase of the edema occurs about one hour ~fter injection 
and has been attributed to the release of histamine, serotonin, and 
kinin-like substances. The second phase of edema, which occurs about 
three hours posti11jection and which is about three times as great 
as the initial phase, has been attributed ~o prostaglandin-like 
substances (37). The recogni.tion of different mediators for different 
phases of the edema has important implications for interpreting the 
mechanism of action of drugs. It should be pointed out at this time, 
however, that the identity of these mediators which are claimed to 
be responsible for the evolution of the edema induced by carrageenin 
is by no means firmly established (37). 
When the velella materials were suspended in 019% saline and 
injected in the same manner as was the carrageenin, a rapid-onset 
carrageenin-like inflammation was produced, but this inflammation 




inflammation persisted (unlike carrageenin) through the twentieth 
day of the observation period (see Table II and Figures 7 - 9). 
Like carrageenin, there was no evidence of the swelling or of the 
development of secondary lesions in the contralateral paws (see 
Table IV and Figures 11 - lJ). 
From these studies, it became apparent that invertebrate 
chitinous materials do possess phlogistic potential (i·~·· can cause 
an inflammatory response) and that the response produced is more 
similar to carrageenin-induced inflammation than to mycobacterium 
adjuvant-induced inflammation. These initial studies confirm one 
of the hypothesis set forth in the introduction -- invertebrate 
chitinous materials do possess phlogistic ability. 
Having documented the phlogistic potential of invertebrate 
chitins, the next step in this study was to determine the minimum 
molecule (s) necessary for indue igg this inflammation, ! . ~. , whether 
or not it was the complete glycoprotein complex, the carbohydrate 
moeity alone, or of the protein alone which was responsible for 
the induction of the inflammatory response. Each species of 
invertebrate chitin studied will now be discussed.individlmlly. 
By studying the results listed in Tables V - X, and illustrated in ~it 
Figures 14 - 27~ a summary table was constructed (Table XIX). From 
this table, the following statements concerning the phlogistic 
capacities of the various forms of invertebrate chitinous materials 
can be made: (~) whole velella material has more phlogistic capacity 
than partly de-acetylated velella material, and partly de-acetylated 
velella material has more phlogistic capacity than deproteinated 
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" Fig. 35 -Effects of aspirin, hydrocortisone, and cryo5enine 
on mean c0ntrala.tcral pa11 volumes of rats 1;i th carrageenin-
induced inflammation. 
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velella material: (ii) whole loligo material has more phlogistic 
capacity than· partly de-acetylated loligo material, and partly de-acety-
lated loligo has more phlogistic capacity than deproteinated loligo 
material; and (!!J) whole shrimp material has more phlogistic capacity 
than the deproteinated shrimp material, and deproteinated shrimp material 
has more phlogistic capacity than the deacetylated shrimp material. 
A trend can be seen for the velella and loligo materials. In 
both cases, the whole forms dominate in phlogistic ability, followed 
by the partly deacetylated and then the deproteinated forms. This 
may mean: (!) that it is the glycoproteu1 complex that is most 
effective in inducing inflammation, (!!) that it is probably the 
protein moeity which is most responsible for the inflammatory effect, 
and (iii) that masking of the glucosamine by the acetyl group may 
actually retard the inflammatory effect of the glucosamine alone. 
The only difference between the deproteinated and partly deacetylated 
forms is the lack of the acetyl groups on the glucosamine in the 
partly deacetylated forms; both forms already have had the protein 
removed. 
It was hoped that the same trend would be observed with the 
shrimp material, i·~·, that the whole material would predominate in 
phlogistic ability followed by the deacetylated form and then by the 
deproteinated forms, but such was not the case. Whole shrimp material 
was dominant in phlogistic ability, but unexpectedly the deproteinated 
shrimp possessed more phlogistic ability than the deacetylated shrimp 
material. Therefore, this could mean 'that· while the shrimp glycoprotein 
complex is most phlogistic, the carbohydrate ·moeity is at least partially 
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responsible for the inflammatory effect since in this case much 
phlogistic capacity is retained even when the shrimp is in the 
deproteinated form. Removing the acetyl group from the glucosamine 
did not improve the phlogistic ability of the shrimp. 
Since the information gathered from studying the velella, 
loligo, and shrimp chitins did not yield consisten results, only 
a few general statements concerning invertebrate chitin inflammation 
and its mechanism of action can be made: (!) invertebrate chitins 
do indeed produce inflanunation; (ii) of the three forms studied, 
velella possesses the greatest phlogistic ability, then shrimp, and 
finally loligo; (iii) chitin-induced inflammation is grossly similar 
to carrageenin-induced inflammation, but less intense and of somewhat 
longer duration, and (!Y) although the minimum molecule or molecules 
necessary for inducing chitin inflammation cannot as yet be identified, 
the whole glycoprotein complex is most phlogistic. More work is 
needed to adequately assess the roles of the carbohydrate and protein 
moeities. Cotton, a polymer of glucose, was tested in this research. 
and found to possess only very minimal phlogistic capacity (see 
Table VII -X). Consequently, we suspect at this time that it is 
the protein moeity of the carbohydrate-protein complex which plays 
the significant role in inducing inflammation. 
In an attempt to identify the mechanism of action by which 
invertebrate chitinous material could induce inflammation, short-term 
single-dose, drug studies were run. Whole velella float material was 
chosen as the type of chitinous material to be examined in these 
studies because of its ready availability and its phlogistic capacity. 
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Theoretically, the information gathe:red concerning whole velella-
induced inflammation should be representative of the whole fo~ms of 
other chitinous materials. 
Since it has been generally agreed that carrageenin-induced 
pedal edema in the rat is the most reliable exudative model extrapo-
lating experimental data to clinical anti-inflammatory effectiveness {38), 
and since the type of inflammation induced by carrageenin is somewhat 
model was ideal for the drug studies conducted here. Prototype, 
clinically effective anti-inflamEatory drugs, including phenylbutazone, 
indomethacin, aspirin, hydrocortisone, and cryogenine, were screened 
in parallel experiments for their anti-inflammatory effectiveness 
against both whole velella-induced inflammation and against carrageenin-
induced inflammation. Chlorpromazine uas studied because it .lacks 
true anti-inflammatory activity in the clinic, yet responds positi-vely 
in carrageenin animal studies. The carrageenin drug studies provided 
us with (i) reference data with which the results from the velella 
drug studies could be compared, and (ii) a possible means of deter-
mining indirectly the mechanism(s) of action by which whole chitinous 
materials can induce inflammation. 
Before proceeding to discuss the effectiveness or non-effective-
ness of each of the aforementioned drugs, it is first necessary to 
review briefly the time course study for both carrageeni..Yl and velella-
induced inflammation as observed in our research. Study of the time-
course of carrageenin-induced edema shows that there is a very sharp 
··- -··-: 
increase in edema formation at +1 hr. after subplantar injection. 
Another increase is noted approximately +3 hr. after injection and 
is maintained up through +5 hr. These results are consistent with 
those obtained by De Cato (39). The time course study of our velel1a-
induced edema, unlike that of carrageenin, did not show a sharp rise 
at +1 hr.; however, like carrageenin, velella did show a sharp rise 
in edema formation +3 hr. after subplantar injection. This edema 
also was maintained through +5 hrs. The amount of edema 
formation was not as intense, however, as that seen with carrageenin. 
It is important to review these time course studies here because 
it has been demonstrated that many anti-inflammatory drugs exert 
their m?.jor effect during either the first or the second phase of 
carrageenin-induced inflammation. 
Phenylbutazone was shown to significantly reduce carrageenin-
induced inflammation by 16% at +3 hr. and b,y 15% at +5 hr.; and to 
significantly reduce whole velella-induced inflammation by 31% 
at +3 hr. and by 33% at +5 hr. (See Tables XIII and XI and Figures 30 
and 28). The mechanism by which phenylbutazone exerts its anti-
inflammatory activity against carrageenin-induced inflammation is 
not thoroughly understood, but it is comparable to the adrenocorti-
" 
costeroids in experimental models (40). 
ACTH, cortisol, and the synthetic analogs of cortisol have 
the capacity to prevent or suppress the development of the local 
heat, redness, swelling, and tenderness by which inflammation is 
recognized at the gross level of observation. At the microscopic 
level, they inhibit not only the early phenomena of the inflammatory 
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process (edema, fibrin dposition, capillary dilation, migration of 
phagocytes to the inflammed area, and phagocytic activity) but also 
the later manifestations (capillary proliferation, fibroblast pro-
liferation, and deposition of collagen) (41). Although there are 
generally no accepted expl~ations for the above facts, many of 
these observations have obvious therapeutic-relevance. Perhaps the 
most important is simply that the corticosteroids inhibit inflammation 
l-~---whe-t-he-r-t-he-b"le-1-t-h~-g-agen-t-i-s-mesha...'l-ical-,-che.!ll.ical-;-Or-inunu..nologica.l-~-------
In clinical terms, the primary cause remains, but the secondary 
manifestations can be suppressed. One can understand why cortisone 
might be suggested for a patS.ent with rheumatoid arthritis who is 
severely ill and has fever, joint swelling, and intense pain. 
Cortisol (hydrocortisone) is the principal glucocorticoid 
secreted by the ad~enal cortex. In adrenalectomized rats, De cato 
demonstrated (42) that phenylbutazone retained some of its anti-
inflammatory properties but there was a shifting of the dose-response 
curve with the lowest "effective" dose becoming ineffective under 
these conditions. This could indicate that part of the anti-inflam-
matory action of phenylbutazone may be mediated through the pituitary-
adrenal axis, and hence explain why phenylbutazone's side effects 
as an anti-inflammatory agent are similar to those of the adreno-
corticoids. 
Indomethacin was shown significantly to reduce carTageenin-
induced inflammation by 32% at +1 hr. and by 30% at +3 hr.; and to 
reduce velella-induced inflammation by 11% at +1 hr. and by 33% 





Indomethacin has been shown to uncouple oxidative phosphorylation 
in cartilagenous and hepatic mitochondria, and its anti-inflammatory 
mechanism of action could be related to this effect (43). It has 
also ,been demonstrated to inhibit the motility of polymorphonuclear 
leucocytes and consequently part of the ant~-inflammatory activity 
could be related to this effect (43). 
Chlorpromazine was shown to significantly reduce carrageenin-
induced inflammation by 29% at +3 hr. and by 20% at +5 hr.; and to 
significantly reduce velella-induced inflammation by 36% at +3 hr. 
and by 40% at +5 hr. (see Tables XIII and XI, and Figures 30 and 
28, respectively). Although chlorpromazine is shwon to be effective 
against carrageenin-induced inflammation, it should be noted that 
it is even more effective in retarding velella-induced inflammation. 
Chlorpromazine has been shown to be anti-inflammatory in a 
variety of experimental models (44, 45) but it lacks effectiveness 
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in the clinical treatment of inflammation. · The variety of pharmacological .. 
effects produced by chlorpromazine make it extremely difficult to 
predict a possible mechanism of action for this compound in this 
instance, Chang (46) suggested that its anti-histaminic, anti-
serotonin and anti-bradykinin activities were not responsible for the 
inhibition of carrageenin-induced pedal edema since cyproheptadine 
(a more potent inhibitor of these substances) was relatively inactive •. 
Arrigoni ··Martelli et !£!.. (47) suggested t.hat its anti-inflammatory 
properties were correlated with its hypothermic activity, but this 
seems doubtful since Garattini et al. (48) demonstrated that 
meprobamate did not inhibit edema formation caused by carrageenin, 
yeast, or dextran when compared at equal hypothermic doses to 
chlorpromazine. Marckel et al. ( L~9) demonstrated that reserpine 
and chlorpromazine cause a release of ACTH and that this may account 
for the anti-inflammatory activity of chlorpromazlne, HoHever, 
reserpine does not inhibit carrageenin -induced J.nflamma tion; and 
De Cato (50) has demonstrated that although chlorpromazlne may 
stimulate the pituitary-adrenal ax:l.s, its anti-inflammatory 
properties cannot be Hholly attributable to this phenomena. 
It should be noted that the dosage of chlorpromazine used :i.n 
this study to effect an inhibition of the inflammatory response 
exceeded its ataract1.c dose in the rat, 
Aspirin was shm·m to significantly reduce carrageenin-induced 
lnflammation by L!lt% a:t +1 hr., by L~l% at +3 hr., and by 27".1a a;t 
+5 hr.; and to significantly reduce velella-induced inflammation 
by 500;b at +1 hr., by 49',1, at +3 hr., and by 237~ at +5 hr. (see Tables 
XVII a.nd XV, and Ingures 34 and 32, respectively). 
A var:l.ety of experimentally induced inflammatory syndromes 
in antmals a.re suppressed by salicylates. Since a cardinal 
feauture of :i.nflarnmaM.on is fluid exudation secondary to increased 
ca pi.llary permea bill ty, attention has been devoted to the possi b:tlity 
that injuries of all types might cause the local tissue release or 
activation of substances (mediators) that increase capillary 
permeability, Many substances proposed as mediators are histamine, 
serotonin, hradykinin, and kallikrein (see Introduction for further 
discussion on mediators). Salicylates, however, do not supppress 
bradykinin formation or prevent the inflammation induced (:p.J H; 
they do not inhibit the kallikrein-bradykinin systemJ nor do they 
antagonize histamine or serotonin (51). Salicylates do stabilize 
the lysosomes and are thought to exert part of their anti-inflammatory 
effect by preventing the release of hydrolases and proteases during 
inflammation. Perhaps the "main mechanism involved is the non-
specific effect of the salicylates to somehow reduce the capillary 
permeability increased by the inflammatory process (51). 
Salicylates also can affect the composition, biosynthesis, 
and metabolism of connective tissue mucopolysaccharides (52). 
This factor offers a possible explanation for the anti-inflammatory 
efficacy of the drug in the treatment of chronic inflammatory disorders. 
Hydrocortisone was shown to significantly reduce.carrageenin-
induced inflammation by 30% at +3 hr.; and to significantly reduce 
velella-induced inflammation by 34% at +3 hr. (See Tables XVII 
and XV and Figures 34 and 32, respectively). 
As stated earlier, hydrocortisone is the principal glucocorticoid 
secreted by the adrenal cortex. It has the capacity to suppress 
the development of inflammation by inhibiting edema formation, fibrin 
deposition, capillary dilation, migration of phagocytes to the 
inflammed area, and also to inhibit fibroblast proliferation and 
the deposition of collagen. Also, as stated earlier, there is 
no generally accepted explanation of these facts (41). It has been 
speculated, hovever, that cortisol suppresses inflammation by 
promoting the containment not only of cathepsins especially, but 
also other enzymes within the lysosomal sac (53). 




treating inflammation resulting from lack of homeostatic control, 
0 
in reality it is not. The reason for this is that there .cu:e 
serious risks associated with its chronic use: (!) cortisone 
therapy, once started, may ~ave to be continued for an undetermined 
time, due to the complications it produces with withdrawl; (ii) with 
prolonged treatment, cortisone may also affect the body's immune 
for the treatment of rheumatoid and osteo-arthritis may cause painless 
destruction of the afflicted joint (54); (iv) sodium retention on chronic 
therapy can precipitate hypertension; ~) atrophy of the adrenal 
cortex can result due to suppression of ACTH; and (vi) wounds heal 
poorly and patients cannot undergo surgical procedures. 
Cryogenine, an alkaloid isolated from Heimia salicifolia, Link 
and Otto, was shown to significantly reduce carrageenin-induced 
inflammation by 28% at +3 hr.; it was not shown to significantly 
• 
reduce velella-induced inflammation (see Tables XVII and XV and 
Figures 34 and 32, respectively). 
Decato (55) demonstrated that the anti-inflammatory effects 
of cryogenine are similar to those of tetrabenzine which ar.e in 
turn similar to those of _chlorpromzaine, and associated with, but 
not necessarily dependent upon, the release of endogenous cortico-
steroids. 
As stated earlier, Vinegar !tl al. (36) have indicated that 
carrageenin-induced edema progresses in two phases. The initial 
phase occurs about one hour after injection and the second phase, 
which is about three times as large as the first, occurs about 
,. 
n 
three hours after injection. The first phase is inhibited by 
aspirin, and is relatively insensitive to hydrocortisone and phenyl-
butazone. Our studies confirmed this. The second phase of 
carrageenin-induced edema is very sensitive to inhibition b,y the 
classical anti-inflammatorj agents such as hydrocortisone, indo-
methacin, and phenylbutazone. Again, our study confirmed this. 
Our study also showed that cryogenine had a more extensive inhibi~ 
--
t1ng efi'ect upon the latter phase of edema formation. This data 
is in agreement with that of Decato (55). 
In summary, all of the above drugs (with the exception of 
cryogenine) displayed a similar pattern of anti-inflammatory 
activity against velella-induced inflammation, possib~y indicating 
that carrageenin and chitinous materials induce inflammation b,y 
a similar mechanism of action. Since cryogenine is a rare alkaloid, 
insufficient material was available to conduct further studies 
attempting to explain why this agent appeared to be an exception. 
Further evidence should be gathered especially relative to 
determining the minimum molecule or molecules involved in initiating 
the inflammatory response with chitina, before this carrageenin-like 






At present, the treatment of inflammatory diseases is 1n 
an unsatisfactory state. Progress is hampered not only by a lack 
of knowledge of the etiology of such diseases, but also b,y the 
lack of information on the many mediators of the inflammatory 
response. Development of therapeutic agents, therefore, is 
taking place against an incomplete theoretical background. Experi-
mental animal models of the human disease are presently inadequate, 
and the drugs now used for treatment are by no means ideal. This 
situation obviously needs to be corrected, but where does research . 
begin? The spectrum of uncertainty is so large. 
These present experi·ments were undertaken in the hope of 
defining an alternative model of inflammation -- a unique system 
different from those utilizing either mycobacterium adjuvant or 
carrageenin. 
Chitinous materials left b,y microorganisms were suggested as 
the possible cause of inflammatory disease and the following 
conclusions about invertebrate chitins were made utilizing animal 
studies: 
(i) chitinous materials are phlogistic; 
151 
(ii) chitinous materials produce inflanmation of less intensity, 
but of longer duration than that produced by carrageenin; 
(iii) chitinous materials produce inflammation completely 
different in character than that produced by mycobacterium 
adjuvant; 
(iv) the partly deacetylated and deproteinated forms of natural 
chitin are not as phlogistic as the natural chitin; and 
l---------------------------
(~) the responses of chitin-induced inflammation to drugs appear 
qualitatively similar to the responses seen with carrageenin-
induced inflammation thereby suggesting similar mechanism{s) 
of action. 
These results suggest a new method for investigating the mechanism{s) 
by which connective tissue diseases are initiated. By extending 
this study, the exact chemical species triggering chitin-induced 
inflammation may be determined, and new avenues for drug design 
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ADDENDUH A 
A STEPWISE CAIJIBllATION OF THE PLETHYSHOGRAPH 
J.. Flip toggle sHi tch .A to "a.rte:dal." 
2. f!'lip toggle svd:t.ch .ll. to "negative." 
1 
______ ~_3_. _Flip toggle mrltch C to "average~- ______________ _ 
4. Flip toggle switch D to "average." 
.5. Turn lr..tlob E to "l mv ./em." (This is an approximate setting). 
6. rl'urn knob li' to "x.l nw./cm." (This i::; an approximate settlng). 
7. Flip toggle sHitch Q. to "out." 
8. De press button l~ to "1 mm. /sec • " 
10. 
'l'u:rn k110b I to "operate" and allow at least JO minutes, but 
pl'efe:cably~- 60 · mil~u tes for machine Harm-up. 
Adjust me:reury level in H shaped tube 1-r:Uh the ffi(~rcury level 
in the reservoir using the syringe which is fHled 1d th distilled 
vrater. 
11. Close the screw clamp which regulates the flovr of water from 
the syringe Hhich ls filled with distilled water. 
12. Flip toggle switch .:!i to "off," turn knob N, and position pen 
6t em. from the top of the stylus paper. 
13. Flip toggle switch B to ''negative, " turn knob 0, and position 




Immerse eal:lbration rod to the 1 ml. mark. 
Turn 1mob 0 and again position pen 6l em. from the top of the 
stylus })aper. 
Immerse the calibration rod to the 2 ml. mark. (This should 
posltlon the pen 7 em. from the top of the stylus paper. If not, 
acljust by turn:l.ng knob p, remember to release the lock on knob P 
l;e:fo:re attempt:lng to turn it! 
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17. Continue to immerse the calibration rod in 1 ml. increments, 
turning knob f slightly to keep the stylus pen positioned at 
. 0.5 em. intervals. 
18. Withdraw the calibration rod. The pen should come to rest 
about 6 or 6t em, from the top of the stylus paper. 
19. Keep repeating step~ ~4 - 18 until linearity is achieved and 
















.A - ARTERIAL/VENOUS SWITCH 
B - +/- POLARITY SWITCH 
C - NORr-1AL/ZERO SUPPRES SWITCH 
D - AVERAGE/10mm Hg.H20 SWITCH 
E - V/CM - MV/CM DIAL PRE-A}W. 
F - V/CM - NV/CM DIAL A}W. 
G - HI IN/OUT SWITCH 
H - PAPER SPEED 1 MM/SEC. 
- '---'-~"'' 
\ 








0 0 0 0 
H 
AMP. 
I ~ OFF/OPERATE SWITCH 
J - STRAIN GAUGE COUPLER 
K - PRESSURE TRANSDUCER 
L - SYRINGE 
M - !11ERCURY RESERVOIR 
N - PERSPEX ROD 
0 - BALANCE DIAL 
K 
TO .1 
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